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 Preface 
 
This thesis is organised into seven chapters, written so that each chapter can be read 
independently. The University of Sydney allows published papers that arise from the 
candidature to be included in the thesis. 
 
Chapter One is an introduction to the thesis and provides an overview of the topics relevant 
to the remaining chapters. 
 
Chapter Two is a systematic review and meta-analysis of longitudinal studies that provides 
estimates of the role of obesity and physical activity on the outcomes of hip and knee 
arthroplasties due to osteoarthritis. The chapter is presented as published in BMJ Open. 
 
Chapter Three is a co-twin longitudinal study investigating whether sex affects the 
prevalence of low back pain when genetic and environmental factors are taken into 
account. This manuscript is presented in the format required by The Clinical Journal of Pain 
where it is under review. 
 
Chapter Four is a systematic review of literature and meta-analysis of the relevant studies 
that provides estimates of the association between diabetes and neck or back pain. The 
chapter is presented as published in the PLoS One Journal. 
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 Chapter Five is a cohort study exploring the association between the level of physical 
activity practised before an acute low back pain episode and recovery from the pain 12 
months after the episode. The chapter is presented as published in the PLoS One Journal. 
 
Chapter Six is a retrospective study using hospital data from NSW to assess the impact of 
comorbidities on the risk of complications after admissions for low back pain and sciatica. 
 
Chapter Seven provides a discussion of the findings and the conclusions of the thesis, 
including implications, and recommendations for future research. 
 
Each chapter contains its own reference list. Relevant appendices published as online 
supplementary material are included after individual chapter. Additional appendices of the 
thesis, unrelated to specific individual chapters, are included after the thesis reference list. 
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 Abstract 
Musculoskeletal pain is a highly prevalent and disabling condition usually presenting with 
physical function loss and incurring substantial health care costs. The burden of 
musculoskeletal pain is expected to increase over the next decades due to the aging 
population and increasing obesity globally. In Europe, the prevalence of musculoskeletal 
pain is reported to range from 12% to approximately 30%, with research reporting the 
prevalence of disability-adjusted life years for musculoskeletal conditions having increased 
60% between 1990 and 2010. The two most common causes of musculoskeletal pain 
worldwide are osteoarthritis and non-specific low back pain. 
Contextual factors related to health conditions may range from lifestyle factors (e.g. practice 
of physical activity, obesity, food intake, and smoking) to people’s individual characteristics 
(e.g. sex, genetic factors, and predisposing conditions). The broad aim of this thesis was to 
investigate the role of specific contextual factors, namely obesity, sex, diabetes, level of 
physical activity and existing comorbidities on the prevalence, prognosis and management 
of musculoskeletal pain. 
One of the most disabling conditions, especially in the elderly population, is osteoarthritis. 
Despite the potential benefits of surgical interventions for the management of osteoarthritis 
and the influence of patient characteristics on the disease progression, there is controversial 
evidence on the association between lifestyle characteristics, namely obesity and physical 
activity participation, on the clinical outcomes of surgical procedures. Chapter Two presents 
a systematic review with meta-analysis of 62 cohort studies. This meta-analysis shows that 
pre-surgical obesity is associated with worse clinical outcomes of hip or knee arthroplasty in 
12
 terms of pain, disability and complications in patients with osteoarthritis. Due to lack of 
relevant studies, the impact of physical activity participation is still unclear. 
Another important cause of disability worldwide is low back pain. It is estimated to have a 
point prevalence of around 18.3%, a 30-day prevalence of 30.8% and a lifetime prevalence 
of 84%. Sex is also one contextual factor believed to influence prevalence of low back pain. 
Chapter Three presents a co-twin control study aiming to quantify the association between 
sex and prevalence of low back pain. The discordant-pair twin analyses showed, however, 
no significant association. These results have challenged previous views on the role of sex as 
a predisposing factor for the development of low back pain.  
Currently, diabetes is also one of the most commonly reported chronic diseases and 
patients with low back and neck pain will often report the co-existence of type 2 diabetes. 
The nature and magnitude of this link was, however, still under-investigated. In this context, 
Chapter Four presents a meta-analysis of studies assessing the association between type 2 
diabetes and the presence of neck, low back or spinal pain (i.e. concurrent back and neck 
pain). The results suggest that diabetes and low back pain or neck pain are significantly 
associated. A direct causal link between them is however, unlikely. 
Recent research shows that exercise, either alone or in combination with education, is an 
effective strategy to prevent new onset of low back pain. In Chapter Five we have 
established whether the level of physical activity participation before an acute episode of 
low back pain predicts recovery within the following 12 months. The findings of this cohort 
study show that pre-pain levels of physical activity participation are not a significant 
predictor of recovery from low back pain. 
13
 Finally, Chapter Six presents a study addressing the effect of comorbidities on the rate of 
hospital complications for people with low back pain and sciatica. The study used hospital 
admitted patient data and the analyses on the potential association between comorbidities 
and hospital complications were adjusted for patient-level (e.g. sex, age) and health care-
level (e.g. type of hospital or access to private health insurance) characteristics. The 
multivariate logistic regression analyses showed that presence of cardiovascular, respiratory 
and renal comorbidities were independently associated with higher rates of in-hospital 
complications. 
The evidence presented in this thesis has established the role of a range of important 
contextual factors on the prevalence, prognosis and management of people with 
musculoskeletal pain. 
14
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CHAPTER ONE - Introduction 
Musculoskeletal pain 
Musculoskeletal pain is a highly prevalent and disabling condition often presenting with ongoing 
loss of physical function [1]. Research evaluating the worldwide burden of musculoskeletal 
diseases has estimated that a total of 2 billion people were affected by at least one 
musculoskeletal condition that causes pain in two decades (between 1990 and 2010) [2]. The 
prevalence of musculoskeletal pain is reported to range from 12% in Spain [3] to approximately 
30% in the United States [4], UK [5], Poland, Italy and Norway [3]. The global burden of disease 
study of 2017 reports the prevalence of disability-adjusted life years for musculoskeletal 
conditions having increased 61.6% between 1990 and 2016 [6]. 
Musculoskeletal pain incurs substantial health care costs [7], and these costs are projected to 
increase due to the increasing prevalence of musculoskeletal pain following the ageing population 
and increasing obesity, globally [8-10]. The financial costs associated with musculoskeletal pain 
include those directly associated with healthcare use (e.g. use of medication, diagnostic imaging, 
surgery) as well as those associated with work absenteeism, productivity loss, and disability 
compensation. The economic burden of musculoskeletal pain in Europe can reach over €200 
billion annually [2]. In Australia, the costs to the health care system with back pain were 
estimated at $2.8 billion in 2015-16; and in the US approximately $635 billion were spent due to 
musculoskeletal pain in 2010 alone [11, 12]. 
Despite the high prevalence and burden of musculoskeletal pain, the roles different biological, 
psychological and socioeconomic factors play on its course remain under investigation [13, 14]. A 
recent systematic review of the literature identified 15 prognostic factors statistically associated 
with a range of musculoskeletal pain conditions in primary care [15]. These included physical (e.g. 
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disability), psychological (e.g. depression and anxiety) and social (e.g. level of education and social 
support) factors. The results of this review show that musculoskeletal pain is associated with 
various aspects of life that need to be accounted for when assessing the course of these 
conditions. 
There is still need, however, for high-quality research that addresses the scientific gaps around 
the role of contextual factors on the risk, prognosis and health care outcomes of musculoskeletal 
pain. Contextual factors are described as factors that interact with the health conditions (e.g. 
musculoskeletal pain) affecting the expected prognosis (e.g. causing longer healing time and 
increasing condition-related disability and function) and include personal (e.g. sex, obesity, 
diabetes) and environmental (e.g. healthcare services availability, leisure areas availability) 
factors [16-20]. This thesis will examine the role of focussed contextual factors on the risk, 
prognosis and management of osteoarthritis and low back pain. 
 
Osteoarthritis 
Osteoarthritis is a disease mainly characterised by an inflammatory process affecting articular 
cartilage, bone, capsule and ligaments of the joint [21]. It is reported to have affected 50 million 
persons in the United States between 2007 and 2009 [22], and approximately 80% of people 
suffering from this condition experience some movement limitation, 25% having serious 
restrictions to activities of daily living [23]. The main complaints of patients with osteoarthritis are 
pain and stiffness, especially following activity, leading to a decrease in physical activity 
participation and physical disability [24]. With the progression of osteoarthritis, there will be 
structural changes to the joint, characterised by synovial thickening, joint space narrowing and 
cartilage loss [25]. Advanced stage osteoarthritis is also characterised by osteophyte formation, 
flattening of the bone area, bone marrow necrosis, cyst formation, joint cartilage lesion and bone 
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contour deformity [25-27]. The most common areas affected by osteoarthritis are the knee, hip 
and hand joints and factors most often associated with the onset of osteoarthritis include age, 
sex, obesity, genetics, prior joint injury and mechanical factors [28-31]. 
Osteoarthritis is characterised by a clinical diagnosis, with the presence of symptoms (e.g. joint 
pain, loss of function and morning stiffness) and physical examination (e.g. restricted or painful 
movement, tenderness of the joint and bone enlargement) being the first tools used to diagnose 
it [32]. Imaging examinations such as magnetic resonance imaging, ultrasound and optical 
coherence tomography may be used to confirm the diagnosis as these methods assess pathology 
of the whole joint, including soft joint tissue [33]. 
 
Prevalence of Lower Limb Osteoarthritis 
The radiographic knee osteoarthritis in adults has a point prevalence of 25%, while the 
symptomatic prevalence can reach 15% [28]. The lifetime risk of developing knee osteoarthritis is 
approximately 40% for men and 47% for women, with 25% of adults older than 55 years reporting 
at least one episode of knee pain per year [28, 31, 34]. Likewise, the point prevalence of 
radiographic hip osteoarthritis is significantly higher (19.6%) than the prevalence of symptomatic 
hip osteoarthritis (4.2%) [35]. The literature shows a weak association linking structural changes 
and symptoms with cartilage volume/thickness not being associated with the presence of pain 
[36]. Due to the ageing of the global population and increasing prevalence of obesity, the 
prevalence and burden of radiographic osteoarthritis are expected to double by 2020 [37, 38]. 
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Financial burden of Osteoarthritis 
Given its increasing prevalence, the costs of osteoarthritis have become a main concern for 
healthcare systems worldwide. In Australia, the health care cost of osteoarthritis in 2015 was $2.1 
billion, and it is expected to increase to $2.9 billion by 2030, with hip and knee osteoarthritis 
accounting for a significant part of this amount due to the costly surgical joint replacements [39]. 
In France, 1.7% of the total health care expenditure (doctor visits, medication and 
hospitalisations) in 2002 was due to osteoarthritis [40], and in the US, the 2007 annual 
expenditure of health care for osteoarthritis was $185.5 billion [41]. Similar to what is observed in 
Australia, a large proportion of the health care costs of osteoarthritis across the world is due to 
the high rates of surgical joint replacement. In 2010, 44% of the health care costs with 
osteoarthritis in Canada were incurred by surgical management and associated hospital costs [42] 
and in 2013 primary total knee arthroplasty was estimated to account for 67% of total costs of 
osteoarthritis treatment in the US [43]. Further understanding of modifiable predictors of poor 
surgical outcomes for knee and hip osteoarthritis (Chapter Two) may be key in improving the 
chance of recovery in these patients. 
 
 
Management of Osteoarthritis 
Osteoarthritis remains an incurable joint disorder [44]. The natural prognosis of hip and knee 
osteoarthritis is usually poor, with the disease evolving to compromise function and movement, 
and also causing pain and swelling [45-47]. The current treatments, therefore, focus on symptom 
relief aiming at improving function and quality of life [48, 49]. 
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The Osteoarthritis Research Society International (OARSI) and European League Against 
Rheumatism (EULAR) clinical guidelines propose that the early management of osteoarthritis 
should focus on non-pharmacological interventions such as education, physical activity and 
weight reduction to manage symptoms. There is good evidence (i.e. 1A and 1B levels of evidence 
according to Oxford Centre for Evidence-based Medicine Levels of Evidence) that education (1A) 
is effective in reducing pain in knee osteoarthritis and physical activity (1B) is effective in reducing 
pain and improving function in knee osteoarthritis [50]. Guidelines also recommend the use of 
orthoses (e.g. walking aids, insoles, bracing) as needed to improve the ability to perform daily 
living activities [50-54]. With the progression of the disease, however, pharmacological 
interventions may be prescribed to reduce pain. There is currently no knowingly effective 
medication to slow disease progression. The most commonly endorsed pharmacological 
approaches include topical agents (e.g. capsaicin and NSAIDs), oral NSAIDs and opioids [54]. The 
latter being used to treat more severe symptoms, given they are associated with substantially 
higher risks of adverse events [44]. Intra-articular corticosteroid injections are rarely 
recommended, as the evidence supporting its effectiveness is inconclusive - there seem to be no 
clinically important benefits of intra-articular corticosteroid injections one to six weeks after the 
treatment for knee osteoarthritis [55]. Surgical intervention is usually the last option to manage 
knee and hip osteoarthritis and in general reserved for those patients who have shown no or little 
improvement with conservative care [44, 50, 51]. There is weak evidence that osteotomy and 
partial joint replacement are more effective than needle lavage and arthroscopy with 
debridement in reducing pain and improving function [54]. There is, however, moderate evidence 
that total joint replacement will improve pain by an average of 14% (SD 20%) assessed using the 
WOMAC pain scale in patients with hip and knee osteoarthritis [56]. When compared to 
conservative care, patients undergoing knee replacement surgery present a two-fold mean 
improvement in all dimensions of the Knee Injury and Osteoarthritis Outcome Score (KOOS) (i.e. 
pain intensity, related symptoms, limitation on activities of daily living and quality of life) [57]. 
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Likewise, hip replacement surgery seems to be more effective in reducing pain and improving 
function than conservative care up to five years after the procedure [58]. 
Despite the benefits of total lower limb joint replacement, there is limited evidence ascertaining 
the role of specific patient characteristics on the surgical outcomes of these procedures [56]. For 
instance, obesity and physical inactivity have already been reported as having a negative effect on 
the prognosis of numerous health conditions, including cardiovascular events, diabetes, and 
osteoarthritis [59-63]. However, the influence of these specific lifestyle factors, together or in 
isolation, on the clinical outcomes of knee and hip surgical joint replacement remains 
controversial [64, 65]. Chapter Two presents a systematic review with meta-analysis of 62 cohort 
studies aiming to quantify the magnitude and direction of the association between obesity or 
physical activity participation and knee or hip surgical outcomes in terms of pain, disability, 
quality of life, and complications. Findings from this study can assist the identification of potential 
subgroups of people with knee or hip osteoarthritis more likely to respond to surgical 
management. 
 
Low Back Pain 
Low back pain is characterised by the presence of pain between the 12th rib and the buttock 
crease [66-69]. It is a common musculoskeletal condition placing a major burden on both 
individuals and society [70]. Low back pain can be categorised according to the duration of the 
episode, being considered acute if it lasts less than six weeks, subacute if episodes last between 
six weeks and three months, and chronic when pain is present for three months or more [71, 72]. 
The prognosis of low back pain is in general positive, with studies reporting a markedly reduction 
in pain intensity from baseline in the first six weeks [73]. 
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Prevalence of Low Back Pain 
Available data was reviewed by Hoy the authors suggested that low back pain have a point 
prevalence of 18.3%, a 30-day prevalence of 30.8% and a 1-year prevalence of 38% [74]. It is the 
greatest contributor to years lived with disability globally [70] and an increase of 54% on the 
disability-adjusted-life-years due to low back pain from 1990 to 2016 [6, 75] has been observed. 
The burden that low back pain places onto society is attributed to its high prevalence rates, 
recurrence rates, associated disability, and direct (e.g. health care expenses) and indirect (e.g. 
production loss) costs incurred by the condition [70, 74, 76, 77]. Approximately 85% of people 
with low back pain do not have a known cause for their condition [78], hence the term ‘non-
specific low back pain’. People of working age (i.e. between 18 and 64 years old) are more likely 
to report back pain. However, around the sixth decade of life, the prevalence of severe low back 
pain increases [79]. Sex is also often believed to be associated with increased prevalence of low 
back pain, and recent reviews have shown a higher prevalence of low back pain in women 
compared to men across all age groups [80, 81]. 
In adolescents aged between 11 and 14 years old, there is evidence suggesting that girls are more 
likely to report low back pain, compared to boys (monthly prevalence of 29% in girls vs 19% in 
boys) [82]. A systematic review included 165 studies reporting general population surveys about 
low back pain and found that women over 18 years old are also believed to present significantly 
higher mean point prevalence and 1-month prevalence of low back pain compared to men, 
although the lifetime prevalence of this condition is similar across sexes [74]. General population-
based studies also point that sex is also associated with pain intensity, duration and frequency of 
episodes, with women reporting more intense pain, more frequent and longer duration episodes 
than men [83]. However, it is still unclear if these findings represent a higher risk for women than 
men to develop low back pain or whether women are more likely to seek care for low back pain 
than men [84]. Another aspect worth considering is the fact that the analysis in these systematic 
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reviews of population studies were not adjusted for genetics and early life environment. These 
are relevant since heritability accounts for up to 67% of the variability in the prevalence of low 
back pain [85]. Early life environment factors, such as learned healthy lifestyle behaviour, eating 
and physical activity behaviours are associated with the risk of developing low back pain and may 
be behaviours carried on over a lifetime [85-87]. Therefore, Chapter Three presents a twin-
control study aiming to quantify the importance of sex as a predictor of low back pain on 
opposite-sex dizygotic twins on three separate twin registries. Findings from this study have 
established the true influence of sex on the prevalence of low back pain in both the community 
(i.e. those not seeking care for the condition) and clinical settings (i.e. people who are seeking 
medical care for low back pain). This finding represents a major scientific advance in the 
epidemiology of low back pain. 
 
Financial burden of Low Back Pain 
Low back pain related disability substantially impacts both the individual, as pain often leads to 
long term limitation of daily living activities [80], and society due to the high costs incurred with 
the management and loss of productivity associated with the condition [88]. The worldwide 
annual expenses related to low back pain are in the order of billions. For instance, the 2008 
estimates of direct and indirect expenditure related to low back pain in the USA added to a total 
of USD118.8 billion [89]. The costs with treatment for low back pain are reported to significantly 
increase with the presence of concurrent comorbidities (US$3,607±10,845 vs US$8,386±17,507; 
p<0.00001) [90, 91]. 
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Comorbidities and Low Back Pain 
Chronic comorbidities commonly reported by people with low back pain include other 
musculoskeletal conditions (e.g. rheumatism, arthritis and osteoarthritis), neuropathic conditions 
(e.g. carpal tunnel syndrome, diabetic neuropathy and atypical facial pain), high blood pressure, 
asthma, headache, depression and anxiety [90, 92]. Diabetes is also a commonly reported co-
existing condition in people with low back pain, and it has been recently suggested that the two 
conditions could be somehow linked by common underlying factors [93-96]. Diabetes is known to 
have a detrimental effect on blood vessels and blood flow, which can affect the physiology of 
spinal structures (e.g. cartilages, ligaments and intervertebral discs) leading to low back pain [97-
101]. Diabetes also shares common risk factors with low back pain such as obesity [102, 103], 
smoking [104] and physical inactivity [105, 106]. However, it remains unclear if there is a causal 
relationship between the two conditions [94]. In this context, Chapter Four presents a systematic 
review with meta-analysis of studies assessing the nature and magnitude of the association 
between diabetes and neck, low back or spinal pain looking to reveal the true link between these 
two conditions. 
 
Prognosis of Low Back Pain 
The prognosis of low back pain is usually satisfactory, with studies reporting a marked reduction 
in pain intensity from baseline in the first six weeks [73]. Healthy lifestyle factors are known to 
influence the prognosis of low back pain [107]. For instance, a recent large cohort study of 8,994 
participants from Sweden found that women who kept a healthy lifestyle behaviour (i.e. no 
smoking, no excessive alcohol consumption, practice of recommended level of physical activity 
and recommended consumption of vegetables) presented a 52% lower risk of developing chronic 
low back pain from an acute episode of low back pain [108]. However, evidence regarding 
10
physical activity engagement as a predictor of recovery from an acute episode of low back pain 
remains scarce. Therefore, Chapter Five presents a 12-month follow-up of the data from Triggers 
for Low Back Pain study investigating whether the level of physical activity participation before an 
acute episode of low back pain predicts recovery within 12 months following the acute pain 
episode. Findings from this study have elucidated the influence of pre-pain physical activity 
participation and the likelihood of recovering from acute low back pain. 
 
Management of Low Back Pain 
It is estimated that 50% of people with non-specific low back pain will seek health care for the 
pain every year [109]. As highlighted by Buchbinder et al while primary care doctors are the most 
commonly visited health care professionals, people with low back pain will also seek care from 
physiotherapists, chiropractors and community workers, specially regarding lifestyle and physical 
activity facilitation [110]. At the early stages of an episode of non-specific low back pain, non-
pharmacological strategies including education and physical activity to improve function and 
reduce symptoms are endorsed [111, 112], with patients being recommended to avoid bed rest 
[111, 113]. In case of patients do not respond to a non-pharmacological approach, pain control 
medication is recommended, with commonly endorsed approaches including NSAIDs and muscle 
relaxants, taking into consideration the drug’s inherent risks [111, 114]. Opioid-based medication 
should be prescribed with care given there is no high-quality evidence attesting its efficacy and 
safety in this population [76, 115]. 
At more advanced stages of low back pain, surgery could be recommended. However, most 
commonly performed surgical procedures lack evidence supporting their effectiveness [114]. For 
instance, a recent systematic review has included 74 randomised controlled trials (n= 7,446 
participants) and found fair quality evidence that spinal fusion is not superior to non-surgical 
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treatments in reducing pain and improving function among patients with low back pain. The 
evidence was rated as fair due to the limited number and quality of included studies [116]. The 
authors also reported that standard open discectomy present small to moderate short-term 
benefits compared to non-surgical care for patients with sciatica [116]. A meta-analysis including 
4 studies (n=634 participants) also found that spinal fusion surgery was not superior to non-
surgical treatments in reducing function for patients with non-specific low back (Mean Diff -4.13; 
95%CI -9.08 to 0.82; 0-100 point scale) [117]. There is also strong evidence that intradiscal steroid 
injection is not superior to sham for patients with spinal stenosis [118]. 
The risk of perioperative and post-operative complications is a major concern when considering 
spinal surgery. The evidence suggests that low back pain surgery can be associated with 
complications, ranging from wound infection to cardiopulmonary complications (e.g. stroke) or 
death. [119]. Better understanding of patient’s characteristics which might be associated to post-
surgical complications would help clinicians and patients make an informed decision on the 
advantages and disadvantages of undergoing spinal surgery. [120]. Little is known, however, 
about the effect of existing multiple comorbidities on the rate of complications of spinal surgery 
and hospitalisation. To address this gap in the literature Chapter Six presents a study addressing 
the effect of comorbidities on the rate of hospitalisation complications for low back pain and 
sciatica. The study used patient-related health care characteristics (e.g. type of hospital) and 
demographic data (e.g. age, sex, marital status) to ascertain the risk of complications associated 
with coexisting chronic conditions including cardiovascular, cerebrovascular, respiratory or renal 
diseases. The study used hospital admitted patient data from NSW between 2003 and 2013. 
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Aims of the thesis 
The broad aim of this thesis was to investigate the role of specific contextual factors, namely 
obesity, sex, diabetes, level of physical activity and existing comorbidities on the prevalence, 
prognosis and management of musculoskeletal pain. This thesis is composed of a series of 
studies, and more precise definitions of relevant variables investigated within each chapter can 
be found at the respective methods sections. 
 
The specific aims of this thesis were to: 
1. Evaluate the role of obesity and physical activity participation as predictors of clinical outcomes 
in terms of pain, disability, quality of life, and post-surgical complications of joint replacements 
due to osteoarthritis (Chapter Two). 
2. Assess the effect of sex on the prevalence of low back pain after adjusting for a range of 
confounders, including genetic and environmental factors, and employing an opposite-sex 
dizygotic twin design with samples from Australia, the USA, and Spain (Chapter Three). 
3. Review and appraise the literature on the magnitude and nature of the association between 
diabetes and low back or neck pain (Chapter Four). 
4. Assess whether pre-pain levels of physical activity participation can predict recovery 12 months 
following the onset of acute low back pain (Chapter Five). 
5. Ascertain the risk of complications after hospital admissions for low back pain and sciatica in 
NSW between 2003 and 2013 (Chapter Six).  
13
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AbstrACt
Objective The aim of this study was to systematically 
review the literature to identify whether obesity or the 
regular practice of physical activity are predictors of 
clinical outcomes in patients undergoing elective hip and 
knee arthroplasty due to osteoarthritis.
Design Systematic review and meta-analysis.
Data source and eligibility criteria A systematic search 
was performed on the Medline, CINAHL, EMBASE and 
Web of Science electronic databases. Longitudinal cohort 
studies were included in the review. To be included, studies 
needed to have assessed the association between obesity 
or physical activity participation measured at baseline and 
clinical outcomes (ie, pain, disability and adverse events) 
following hip or knee arthroplasty.
Data extraction Two independent reviewers extracted 
data on pain, disability, quality of life, obesity, physical 
activity and any postsurgical complications.
results 62 full papers were included in this systematic 
review. From these, 31 were included in the meta-
analyses. Our meta-analysis showed that compared to 
obese participants, non-obese participants report less 
pain at both short term (standardised mean difference 
(SMD) −0.43; 95% CI −0.67 to −0.19; P<0.001) and long 
term post-surgery (SMD −0.36; 95% CI −0.47 to −0.24; 
P<0.001), as well as less disability at long term post-
surgery (SMD −0.32; 95% CI −0.36 to −0.28; P<0.001). 
They also report fewer postsurgical complications at short 
term (OR 0.48; 95% CI 0.25 to 0.91; P<0.001) and long 
term (OR 0.55; 95% CI 0.41 to 0.74; P<0.001) along with 
less postsurgical infections after hip arthroplasty (OR 0.33; 
95% CI 0.18 to 0.59; P<0.001), and knee arthroplasty (OR 
0.42; 95% CI 0.23 to 0.78; P=0.006).
Conclusions Presurgical obesity is associated with 
worse clinical outcomes of hip or knee arthroplasty in 
terms of pain, disability and complications in patients with 
osteoarthritis. No impact of physical activity participation 
has been observed.
PrOsPErO registration number CRD42016032711.
IntrODuCtIOn 
Musculoskeletal pain, including pain from 
knee and hip osteoarthritis (OA), is the 
leading cause of physical disability in the 
world and responsible for an increasing 
burden to patients and society.1 This problem 
will increase over time, as the world popu-
lation ages and physical disability resulting 
from declining health becomes increasingly 
prevalent.2 The global healthcare expendi-
ture for knee and hip OA is substantial, and 
most of these costs are incurred by surgical 
management and associated hospital care.3 
For instance, in the UK, the direct costs of 
OA were estimated at more than £1 billion in 
2010, of which £850 million was spent just on 
surgical procedures.4 
Although management of the early stages 
of this condition consists of a combination of 
non-pharmacological and pharmacological 
therapies (eg, anti-inflammatory and anal-
gesic drugs), surgery has become the most 
common treatment option for severe cases, 
especially when non-surgical therapies fail 
to provide sufficient pain relief.5 Osteotomy, 
mosaicplasty and arthroplasty are some of 
the existing types of surgery used to manage 
OA of the hip and knee; with total or partial 
arthroplasty being the most commonly 
recommended.6
strengths and limitations of this study
 ► The current review is the most comprehensive 
systematic review on the topic to date.
 ► The current review is the first review to use a 
quantitative approach to synthesise the results of 
pain, disability and surgical complications between 
non-obese and obese participants who underwent 
hip or knee arthroplasty due to osteoarthritis.
 ► The methodological quality of the included studies 
was in general poor.
 ► There was a substantial variability of follow-up 
duration across studies, ranging from 2 weeks to 
11 years.
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There are multiple risk factors for the development 
of knee OA. Among the most common of these are 
increased body weight and muscle weakness; often 
attributed to a sedentary lifestyle.7 Obesity and sedentary 
lifestyle behaviour have also been associated with serious 
health conditions such as: coronary heart disease, type 
2 diabetes, breast and colon cancers and decreased life 
expectancy.8 Although there is evidence for the role of 
obesity and physical inactivity in health conditions and 
quality of life in general,9 10 the actual impact of these 
factors, together or in isolation, on the outcomes of 
elective surgery of the knee and hip is still controver-
sial.11 12 Although previous attempts to systematically 
review the literature have been made, these studies13–15 
have either failed to perform a quantitative summary of 
the evidence (ie, meta-analysis), have excluded patients 
undergoing knee arthroplasty16 or have excluded pain 
outcomes.13 No meta-analyses have been performed 
considering obesity and physical activity as predictors of 
surgical outcomes in terms of pain, disability, quality of 
life and complications after hip or knee arthroplasty for 
end-stage OA.
Identifying whether obesity and physical activity partic-
ipation predict surgical outcomes in patients with knee 
and hip OA will inform clinical practice in terms of prog-
nosis and safety of an increasingly prevalent treatment 
approach. We have conducted a meta-analysis of cohort 
studies aiming to quantify the role of obesity and physical 
activity participation as predictors of clinical outcomes in 
terms of pain, disability, quality of life and postsurgical 
complications. This review and meta-analysis focused on 
patients with knee and hip OA undergoing hip or knee 
arthroplasty.
MEthODs
Data sources and searches
We conducted a systematic review following the PRISMA 
statement.17 This review was prospectively registered on 
PROSPERO, registration number CRD42016032711. 
A systematic electronic search was performed in the 
following databases from inception to January 2017: 
MEDLINE, EMBASE, CINAHL and Web of Science. We 
used a combination of relevant keywords to construct the 
search strategy including obesity, physical activity, knee 
OA, hip OA, arthroplasty and elective surgery (online 
supplementary appendix 1). The first screening of poten-
tially relevant records was conducted by one author 
(DP) based on titles and abstract, and two authors (DP 
and GCM) independently performed the final selection 
of included trials based on full-text evaluation. A third 
reviewer arbitrated in case of disagreement (MLF). More-
over, the reference lists of included studies were checked 
for potential studies. An additional 26 references were 
screened, but none met our inclusion criteria. No restric-
tion was applied on language.
study selection
We included only longitudinal studies assessing the role 
of obesity or physical activity participation on the clinical 
outcomes following partial or total hip arthroplasty (THA) 
or partial or total knee arthroplasty (TKA) surgery. Clin-
ical outcomes were defined in terms of pain, disability, 
quality of life and complications after arthroplasty. To 
be eligible, studies had to be full reports; include partic-
ipants who underwent elective arthroplasty of the hip or 
knee due to OA; include data of presurgical and at least 
one postsurgical assessment of the clinical outcomes of 
interest; and assess the association between the predictors 
and outcomes of interest. Obesity and physical activity 
participation had to be assessed at baseline. Studies on 
revision surgery were excluded. Studies were not excluded 
based on intensity or duration of symptoms.
Data extraction
Using a standardised form, data on study characteris-
tics, predictors and outcome measures of interest were 
independently extracted from the included studies by 
two reviewers (DP and GCM). A third author (MLF) 
resolved any disagreement. Estimates of association 
between predictors and outcomes of interest were 
extracted as presented in each study and included ORs, 
risk ratios (RR), correlations, mean differences (MD) or 
regression coefficients. When studies reported more 
than one tool regarding the same topic (eg, Western 
Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC), Hip Disability and Osteoarthritis Outcome 
Score (HOOS), Oxford Hip Score (OHS), Knee Injury 
and Osteoarthritis Outcome Score (KOOS), Knee Society 
Score (KSS)), estimates were extracted from the group 
with the largest sample size.
We contacted the authors to provide further informa-
tion when there were insufficient data reported in the 
manuscript. When authors were unavailable we estimated 
data using the recommendations in the Cochrane Hand-
book for Systematic Reviews of Interventions.18
Outcome measures
Data on pain intensity were extracted as visual analogue 
scale scores ranging from 0 to 10 and measured directly or 
as part of the following measurement tools: the WOMAC, 
the HOOS, the KOOS or the Harris Hip Score (HHS). If 
studies reported more than one measure of pain intensity 
or disability for the cohort, the most severe measure at 
baseline was included in the pooled analyses. Disability 
measures included the OHS ranging from 12 to 60, with 
12 being the best result; Oxford Knee Score ranging from 
0 to 60, with 60 being the best result; the HHS ranging 
from 0 to 100, with 100 being the best result; KSS ranging 
from 0 to 100, with 100 being the best result; WOMAC 
total score ranging from 0 to 96, with 0 being the best 
result; or WOMAC function subscale ranging from 0 to 
10, with 10 being the best result; and were converted 
into a uniform 0–100 scale where 0 meant less disability. 
Extracted data on complications included any descriptive 
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measure of the number of complications or number of 
patients with a complication reported during the study. 
Only two of the screened studies had reported specific 
raw data on quality of life among the participants after 
joint arthroplasty, but due to differences in follow-up 
length, any meta-analysis made by merging these data 
would result in an unreliable measure.
Methodological quality assessment
The methodological quality of included studies was 
assessed by two independent reviewers using the Newcas-
tle-Ottawa Scale (NOS)19 recommended by the Cochrane 
Collaboration.18 The NOS consists of eight items grouped 
into three categories, namely: selection, comparability 
and outcome. A star system, ranging from zero to nine 
stars, is used to classify the quality of the study being 
reviewed (the more stars the study receives in each 
category, the higher its methodological quality). After 
the independent assessment of included studies by the 
leading author, each study received the following cate-
gorical scores representing its quality: good (three or 
four stars in selection domain AND one or two stars in 
comparability domain AND two or three stars in outcome 
domain), fair (two stars in selection domain AND one or 
two stars in comparability domain AND two or three stars 
in outcome domain) or poor (zero or one star in selec-
tion domain OR zero star in comparability domain OR 
zero or one star in outcome domain). A third reviewer 
(MLF) resolved any disagreement between independent 
assessors. Methodological quality scores for included 
studies are presented in table 1.
Data analysis
Data on baseline (ie, presurgical scores) and postoper-
ative outcome scores were weighed by the inverse study 
variance and used in fractional polynomial regression 
modelling to build graphs depicting the course of pain 
and disability over time. STATA V.14 was used for the 
analyses (StataCorp, College Station, TX).20
Meta-analyses were performed to assess the differences 
in pain, disability and complications after surgery, between 
predictor groups (ie, obese and non-obese groups as 
defined by included studies), using a random effects 
model. When possible, different analyses were performed 
for knee and hip arthroplasty and also for different 
levels of obesity (ie, obesity and morbid obesity). When 
means and SD of outcomes of interest were presented for 
multiple predictor groups in the same study (ie, under-
weight (body mass index (BMI)<18), normal weight 
(BMI≥18<25), overweight (BMI≥25<30) and obese level 
I (BMI≥30<35), II (BMI≥35<40) or III (BMI≥40)) these 
were combined into two groups (non-obese: BMI<30 and 
obese: BMI≥30) as recommended in the Cochrane Hand-
book for Systematic Reviews of Interventions18 before 
inclusion in the pooled analyses. Results were reported 
as standardised mean differences (SMD) and 95% CIs. 
Between-study heterogeneity was calculated using I2 
(I2<25%: small heterogeneity; 25%<I2<75%: moderate 
heterogeneity; I2>75%: large heterogeneity).21 We have 
defined an SMD of 0.2 as small difference, 0.5 as moderate 
difference and 0.8 as large difference.22
Assessment of publication bias was performed using 
funnel plots. The precision (ie, SE) of included studies 
was plotted against the difference in outcomes between 
groups (ie, obese or non-obese) and results visually anal-
ysed. In the absence of publication bias or small study bias, 
smaller studies should be evenly spread around the base 
of the funnel, while the larger studies should be concen-
trated around the top of the funnel. Plot asymmetry was 
also quantified using the Egger’s tests, for which a null 
hypothesis represents symmetry of plotted data.23
All meta-analyses were conducted using Comprehen-
sive Meta-Analysis software (Comprehensive Meta-Anal-
ysis, Englewood, NJ). For studies not reporting enough 
data to be included in the meta-analyses, the reported 
individual associations were tabulated and qualitatively 
presented in tables 2–5.
rEsults
Our search strategy identified 11 990 studies. After 
removing 381 duplicates, 11 221 studies were screened 
and excluded based on keywords, titles and abstracts. All 
the remaining 388 studies were written in English and 
were assessed by reading the full text, of which 326 were 
then excluded, yielding 62 studies to be included in the 
systematic review.24–85 From these, 31 presented enough 
data to be included in at least one of the meta-analyses 
(figure 1).
Included studies
Included studies reported data from 18 different 
countries: Australia,40 47 72 85 Canada,38 43 78 China,84 
Denmark,60 England,27 30 Finland,49–52 France,65 73 
Germany,55 75 81 Italy,28 29 Japan,83 Netherlands,57 76 Norway,45 
Scotland,25 36 South Korea,56 Spain,41 80 Switzerland,61 62 69 
UK26 35 37 46 48 53 63 67 68 71 74 and USA.24 31–34 39 42 44 54 58 59 64 66 70 77 79 82 
Demographic data from each study are presented in table 1.
Methodological quality
An overall quality assessment of the studies showed that 
50% (n=31) of the included studies were considered as 
being of good methodological quality, while 1.5% (n=1) 
were considered fair and 48.5% (n=30) were considered 
of poor methodological quality. Of the screened studies, 
56 (90%) had a follow-up rate of 80% or greater, and only 
half (n=32 studies) assessed outcomes via retrospective 
analysis of medical records, conducted adjustment for 
potential confounders (eg, age or sex) or investigated a 
representative sample of the population (online supple-
mentary appendix 2).
Assessment of publication bias
Inspection of funnel plots and results of Egger’s test 
confirmed no evidence of small study bias for those 
studies included in our pooled analyses, with P values 
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Table 1 Included studies and characteristics
Author, year Country
Sample 
size Predictor Outcomes Surgery
Follow-
up duration
Quality
score
AbdelSalam et al, 
201224
USA 210 Obesity Complications Total hip and knee 
arthroplasty
9 years Fair
Amin et al, 200626 UK 328 Obesity Complications; 
disability
Total knee 
replacement
6, 18, 36 and 
60 months
Poor
Amin et al, 200625 Scotland 82 Obesity Complications Total knee 
replacement
38.5 months Poor
Andrew et al, 200827 England 1059 Obesity Complications; 
disability
Total hip 
arthroplasty
3, 12, 24, 36 and 
60 months
Poor
Sadr Azodi et al, 200629 Italy 3309 Obesity Complications Total hip 
replacement
6–9 years Fair
Sadr Azodi et al, 200828 Italy 2106 Obesity Complications Total knee 
arthroplasty
2 years Fair
Baker et al, 201230 England 13 673 Obesity Complications; 
disability
Total hip 
arthroplasty
6 months Fair
Belmont et al, 201431 USA 17 514 Obesity Complications Total knee 
arthroplasty
1 month Fair
Belmont et al, 201432 USA 15 321 Obesity Complications Total knee 
arthroplasty
1 month Fair
Bozic et al, 201234 USA 40 919 Obesity Complications Total hip 
arthroplasty
10 years Fair
Bozic et al, 201233 USA 83 011 Obesity Complications Total knee 
arthroplasty
10 years Fair
Chee et al, 201035 UK 106 Obesity Complications; 
disability
Total hip 
arthroplasty
6, 18, 36 and 
60 months
Good
Chesney et al, 200836 Scotland 1278 Obesity Complications Total knee 
arthroplasty
6, 18 and 
60 months
Poor
Collins et al, 201237 UK 385 Obesity Complications; 
disability
Total knee 
arthroplasty
6 and 18 months
3, 6 and 9 years
Poor
Davis et al, 201138 Canada 931 Obesity Pain Total hip and knee 
arthroplasty
2 weeks
1, 3, 
6 and 12 months
Fair
Dewan et al, 200939 USA 220 Obesity Complications; 
disability
Total knee 
arthroplasty
5.4 years Poor
Dowsey and Choong, 
200885
Australia 1207 Obesity Complications Hip arthroplasty 1 year Poor
Dowsey et al, 201040 Australia 471 Obesity Complications; 
pain; disability
Total hip 
arthroplasty
1 year Good
Font-Vizcarra et al, 
201141
Spain 402 Obesity Complications Total hip 
arthroplasty
3 months Fair
Friedman et al, 201342 USA 12 355 Obesity Complications Hip and knee 
arthroplasty
2 months Poor
Gandhi et al, 201043 Canada 1224 Obesity Pain; disability Total hip 
arthroplasty
1 year Good
Hamoui et al, 200644 USA 63 Obesity Disability Total knee 
arthroplasty
11.3 years Poor
Heiberg et al, 201345 Norway 64 Obesity Pain Total hip 
arthroplasty
3 and 12 months Good
Ibrahim et al, 200546 UK 343 Obesity Complications Total hip 
arthroplasty
1 year Poor
Jackson et al, 200947 Australia 100 Obesity Complications; 
pain; disability
Total knee 
replacement
9.2 years Poor
Continued
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Author, year Country
Sample 
size Predictor Outcomes Surgery
Follow-
up duration
Quality
score
Jameson et al, 201448 UK 5535 Obesity Disability Hip arthroplasty 6 months Fair
Jämsen et al, 201050 Finland 2647 Obesity Complications Total knee 
arthroplasty
1 year Good
Jämsen et al, 201249 Finland 7181 Obesity Complications Total knee 
arthroplasty
1 year Good
Järvenpää et al, 201051 Finland 100 Obesity Complications; 
pain
Total knee 
arthroplasty
3 months Poor
Järvenpää et al, 201252 Finland 52 Obesity Pain; disability Total knee 
arthroplasty
10.8 years Poor
Judge et al, 201053 UK 908 Obesity Disability Hip replacement 1 year Poor
Kandil et al, 201554 USA 15 770 Obesity Complications Unicompartmental 
knee arthroplasty
3 months Poor
Kessler and Käfer, 
200755
Germany 67 Obesity Disability Total hip 
replacement
10 days and 
3 months
Good
Kim et al, 201156 South Korea 227 Obesity Complications Total knee 
arthroplasty
6 months Poor
Kort et al, 200757 Netherlands 46 Obesity Complications Unicompartmental 
knee replacement
2 years Poor
Ledford et al, 201458 USA 316 Obesity Complications Total hip and knee 
arthroplasty
2 months Poor
Liabaud et al, 201359 USA 273 Obesity Complications Total knee 
arthroplasty
3 and 12 months Poor
Liljensøe et al, 201360 Denmark 197 Obesity Pain; disability Total knee 
arthroplasty
4 years Poor
Lübbeke et al, 200762 Switzerland 2495 Obesity Complications; 
disability
Total hip 
arthroplasty
5 years Good
Lübbeke et al, 200762 Switzerland 325 Obesity Disability Total hip 
arthroplasty
5 years Good
Mackie et al, 201563 UK 1821 Obesity Complications; 
pain; disability
Total knee 
arthroplasty
1 year Poor
Madsen et al, 201464 USA 79 Obesity Complications Total knee 
arthroplasty
10 years Poor
Maisongrosse et al, 
201565
France 502 Obesity Complications Total hip 
arthroplasty
58 months Poor
McLaughlin and Lee, 
200666
USA 198 Obesity Complications Total hip 
replacement
14.5 years Poor
Michalka et al, 201267 UK 191 Obesity Complications; 
pain; disability
Hip arthroplasty 6 weeks Poor
Murray et al, 201368 UK 2438 Obesity Complications; 
disability
Unicompartmental 
knee replacement
1 year Poor
Naal et al, 200969 Switzerland 83 Obesity Pain; disability Total knee 
arthroplasty
6 weeks
3, 12 and 
24 months
Poor
Namba et al, 200570 USA 1813 Obesity Complications Total hip and knee 
arthroplasty
1 year Poor
Napier et al, 201471 UK 100 Obesity Complications; 
disability
Total knee 
arthroplasty
3 and 12 months Poor
Naylor et al, 200872 Australia 99 Obesity Pain Total hip and knee 
arthroplasty
2, 6, 12, 26 and 
52 weeks
Good
Table 1 Continued 
Continued
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Author, year Country
Sample 
size Predictor Outcomes Surgery
Follow-
up duration
Quality
score
Ollivier et al, 201273 France 210 Physical 
activity
Disability Total hip 
arthroplasty
10 years Fair
Patel and Albrizio, 
200874
UK 527 Obesity Complications Total knee 
replacement
4 weeks, 6 weeks 
and 1 year
Good
Pietschmann et al, 
201375
Germany 171 Physical 
activity
Disability Unicompartmental 
knee arthroplasty
4.2 years Poor
Poortinga et al, 201476 Netherlands 658 Physical 
activity
Disability Total hip and knee 
arthroplasty
1 year Good
Pulido et al, 200877 USA 9245 Obesity Complications Total hip and knee 
arthroplasty
1 year Fair
Rajgopal et al, 200878 Canada 760 Obesity Complications; 
disability
Total knee 
arthroplasty
1 year Fair
Sechriest et al, 200779 USA 34 Physical 
activity
Disability Total hip 
arthroplasty
5 years Poor
Aranda Villalobos et al, 
201380
Spain 63 Obesity Pain; disability Total hip 
arthroplasty
3 months Good
Vogl et al, 201481 Germany 281 Obesity Disability Total hip 
arthroplasty
6 months Poor
Wang et al, 201082 USA 97 Obesity Disability Total hip 
arthroplasty
3 months
1 and 2 years
Fair
Yasunaga et al, 200983 Japan 3577 Obesity Complications Total knee 
arthroplasty
5 months Fair
Zhang et al, 201284 China 714 Obesity Complications; 
disability
Total hip 
arthroplasty
5 years Poor
Table 1 Continued 
Table 2 Results of individual studies on the association between postsurgical pain and baseline obesity
Obesity versus pain
Author, year
BMI: mean 
(SD) Measure Results
Knee
  Davis et al, 201138 NA HOOS/KOOS After adjusting for age, gender, joint and presence of back pain, an 
increased BMI was associated with worst pain outcomes (P<0.02) 
at long term after THA or TKA.
  Järvenpää et al, 201051 29.7 (NA) VAS Increased BMI correlates significantly to VAS pain scale (r=0.236; 
P=0.018) at short term after TKA.
  Liljensøe et al, 201360 30 (NA) SF-36 BMI was not associated with SF-36 pain scale (OR=0.96; P=0.1) at 
long term after TKA.
  Mackie et al, 201563 NA WOMAC Increased BMI was associated with less improvement in WOMAC 
pain scale (t=−2.64; P<0.001) at long term after TKA.
Hip
  Dowsey et al, 201040 29.55 (5.64)* Harris Hip 
Score
BMI was not associated with pain reduction (P=0.71) at long term 
after THA.
  Heiberg et al, 201345 27 (6.27)* HOOS BMI was not associated with HOOS pain scale (P>0.05) at short 
term after THA.
*Calculated following guidelines from Cochrane Handbook for Systematic Reviews of Interventions.
BMI, body mass index; HOOS, Hip Dysfunction and Osteoarthritis Outcome Score; KOOS, Knee Injury and Osteoarthritis Outcome Score; 
NA, none available; SF-36, Short Form 36 Questionnaire; THA, total hip arthroplasty; TKA, total knee arthroplasty; VAS, visual analogue scale; 
WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
group.bmj.com on March 4, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
34
7Pozzobon D, et al. BMJ Open 2018;8:e017689. doi:10.1136/bmjopen-2017-017689
Open Access
ranging from 0.07 to 0.43 (online supplementary appen-
dices 3–5).
The course of pain and disability over time
The fractional polynomial regression model resulted 
in a pooled mean disability score and SD before hip 
arthroplasty of 59.42 (SD: 10.94; n=5250). At 12 months 
after surgery it had decreased to a mean of 31.31 (SD: 
24.28; n=3017) and a further reduction was observed at 
120 months, when the mean disability score after hip 
arthroplasty was 24.32 (SD: 19.53; n=210). For knee 
OA, a pooled mean disability score of 56.88 (SD: 10.74; 
n=17 225) was observed for patients undergoing arthro-
plasty. At 12 months after surgery this value decreased 
to 21.80 (SD: 13.51; n=2898), while at the 110-month 
follow-up, the mean disability score was 14.18 (SD: 0.77; 
n=485). The pooled mean pain score before hip arthro-
plasty was 54.86 (SD: 10.20; n=2517), decreasing to 13.76 
(SD: 1.32; n=1058) 3 months after surgery, 10.8 (SD: 1.69; 
n=1212) at 6 months and slightly increasing to 13.45 (SD: 
Table 3 Results of individual studies on the association between postsurgical disability and baseline obesity
Obesity versus disability
Author, year BMI: mean (SD) Measure Results
Knee
  Davis et al, 201138 NA WOMAC/KOOS After adjusting for age, gender, joint and presence of back 
pain, an increased BMI was associated with worst outcomes 
(P<0.02) at long term after TKA or THA.
  Dewan et al, 200939 31 (0.5) Knee Society 
Score
BMI was not associated with worst knee function (P>0.119) 
at long term after TKA.
  Hamoui et al, 200644 27.93 (7.1)* Knee Society 
Score
No significant association between BMI and KSS (P>0.05) 
was found at long term after TKA.
  Kort et al, 200757 NA WOMAC Obesity was not related to disability score (P>0.05) at long 
term after TKA.
  Liljensøe et al, 201360 30 (NA) Knee Society 
Score
Increased BMI was associated with worst knee scores (OR 
0.95; 95% CI 0.9 to 1.0; P=0.04) at long term after TKA. These 
results did not change significantly after adjusting for age, 
sex, primary disease and surgical approach (OR 0.94; 95% CI 
0.90 to 0.99; P=0.02).
  Mackie et al, 201563 NA WOMAC Increased BMI was associated with less improvement in 
disability scores (WOMAC t=−2.13; P=0.033) at long term 
after TKA.
  Rajgopal et al, 200878 32.3 (6.58)* WOMAC The morbidly obese group (BMI≥40, n=69) does not present a 
statistically significant difference in improvement in WOMAC 
score (P=0.669) when compared with other BMI groups at 
long term after TKA.
Hip
  Heiberg et al, 201345 27 (6.27)* HHS Increased BMI was associated with lower HHS (P<0.05) at 
short term after THA.
  Jameson et al, 201448 NA OHS Increased BMI was not associated with changes in OHS 
(P>0.05) at short term after THA.
  Lübbeke et al, 200762 26.4 (4.3) HHS Increased BMI was associated with lower hip score (r=−0.4, 
95% CI −0.8 to −0.1) at long term after THA.
  McLaughlin and Lee, 
200666
26 (NA) HHS The obese group (BMI≥30; n=95) did not present any 
statistically significant difference from the non-obese group 
(BMI<30, n=103) with regard to clinical outcomes assessed 
by HHS (P>0.05) at long term after THA.
  Vogl et al, 201481 26.9 (4.9) WOMAC Obesity was associated with changes in WOMAC score 
(P<0.05) at short term after THA.
  Wang et al, 201082 29.14 (6.23) WOMAC Increased BMI was not associated with WOMAC score 
(P=0.114) at long term after THA.
*Calculated following guidelines from Cochrane Handbook for Systematic Reviews of Interventions.
BMI, body mass index; HHS, Harris Hip Score; KOOS, Knee Injury and Osteoarthritis Outcome Score; KSS, Knee Society Score; NA, none 
available; OHS, Oxford Hip Score; r, coefficient of association; SF-36, Short Form 36 Questionnaire; THA, total hip arthroplasty; TKA, total 
knee arthroplasty; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
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7.87; n=2173) at the 12-month follow-up. For patients 
undergoing knee arthroplasty, the pooled pain score at 
baseline was 57.78 (SD: 9.28; n=2211), which decreased 
to 25.67 (SD: 6.61; n=1222) at 6 months, and 14.18 (SD: 
0.77; n=1820) at the 12-month follow-up (figure 2).
Association between obesity and postsurgical pain outcomes
Fourteen studies investigated the association between 
obesity and pain intensity in a total of 5687 patients after 
hip or knee arthroplasty. Seven of the 14 studies presented 
enough data to be pooled in a meta-analysis. There was 
an overall moderate and statistically significant differ-
ence in postsurgical pain between obese and non-obese 
patients after arthroplasty, with non-obese patients having 
better outcomes at short-term timepoint (SMD −0.44; 
95% CI −0.68 to −0.20; P<0.001) and long-term timepoint 
(SMD −0.36; 95% CI −0.47 to −0.25; P<0.001). The pooled 
results for separate joints suggest non-obese participants 
have significantly less short-term (ie, less than 6 months) 
postsurgical knee pain, compared with obese partici-
pants (SMD −0.55; 95% CI −0.90 to −0.20; P=0.002) and 
postsurgical hip pain (SMD −0.34; 95% CI −0.67 to −0.02; 
P=0.039). Obesity was defined as having a BMI over 
30 kg/m2. At long term (ie, 6 months or longer), there 
was a significant moderate difference between obese and 
non-obese groups in terms of knee pain (SMD −0.36; 
95% CI −0.48 to −0.25; P<0.001); however, there was no 
difference between groups for hip pain (SMD −0.32; 
95% CI −0.84 to 0.20; P=0.222) (figure 3). The results of 
individual studies not included in the pooled analyses are 
presented in table 2.
Association between obesity and postsurgical disability outcomes
The impact of obesity on disability was investigated 
by 32 studies which compared postsurgery disability 
scores in 35 286 obese and non-obese participants. Of 
these, 19 studies presented complete data that were 
included in the pooled analysis. At short term, no statis-
tically significant difference in overall disability between 
obese and non-obese participants was observed (SMD 
−0.16; 95% CI −0.42 to 0.10; P=0.231). Likewise, no statis-
tically significant difference was observed between obese 
Table 4 Results of individual studies investigating the association between obesity and postsurgical complications
Obesity versus complications
Author, year BMI: mean (SD) Measure Results
Ollivier et al, 201273 25.13 (3.14)* HHS/HOOS
Pietschmann et al, 
201375
28.4 (4.62)* OKS At long term, physical activities were not related to complications 
(P<0.01). Physically active patients had less pain and better OKS 
scores after UKA.
Poortinga et al, 201476 28.7 (4.9) WOMAC At long term, physical activity was not associated with WOMAC 
score (P>0.05) after THA or TKA.
Sechriest et al, 200779 28.1 (8.3) UCLA At long term increased BMI was not correlated to UCLA physical 
activity score (r=−0.07; P=0.67) after TKA.
*Calculated following guidelines from Cochrane Handbook for Systematic Reviews of Interventions.
BMI, body mass index; HHS, Harris Hip Score; HOOS, Hip disability and Osteoarthritis Outcome Score; OKS, Oxford Knee Score; r, 
coefficient of association; THA, total hip arthroplasty; TKA, total knee arthroplasty; UCLA, University of California, Los Angeles Activity 
Questionnaire; UKA, unicompartmental knee arthroplasty; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
Table 5 Individual results on the association between physical activity and pain or disability
Physical activity versus disability
Author, year
BMI: mean 
(SD) Measure Results
Ollivier et al, 201273 25.13 (3.14)* HHS/HOOS At long term, high-impact sports were associated with better 
HHS (P<0.001) and HOOS (P<0.05) after THA.
Pietschmann et al, 
201375
28.4 (4.62)* OKS/KSS/WOMAC At long term, physical activities were not related to 
complications. Physically active patients had less pain and better 
OKS, KSS and WOMAC scores (P<0.05) after UKA.
Poortinga et al, 
201476
28.7 (4.9) WOMAC At long term, physical activity was not associated with WOMAC 
score (P>0.05) after THA or TKA.
Sechriest et al, 
200779
28.1 (8.3) UCLA At long term increased BMI was not correlated to UCLA physical 
activity score (r=−0.07; P=0.67) after TKA.
*Calculated following guidelines from Cochrane Handbook for Systematic Reviews of Interventions.
BMI, body mass index; HHS, Harris Hip Score; HOOS, Hip disability and Osteoarthritis Outcome Score; KSS, Knee Society Score; OKS, 
Oxford Knee Score; r, coefficient of association; THA, total hip arthroplasty; TKA, total knee arthroplasty; UCLA, University of California, 
Los Angeles Activity Questionnaire; UKA, unicompartmental knee arthroplasty; WOMAC, Western Ontario and McMaster Universities 
Osteoarthritis Index.
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and non-obese participants for postsurgical knee or hip 
disability (SMD −0.42; 95% CI −1.0 to 0.16; P=0.159 and 
SMD −0.09; 95% CI −0.39 to 0.20; P=0.527, respectively).
At long-term follow-up, however, there was an overall 
moderate and statistically significant difference in post-
surgical disability between obese and non-obese patients 
regardless of the joint affected (SMD −0.32; 95% CI −0.37 
to −0.28; P<0.001). That difference was still statistically 
significant and of moderate magnitude when knee and 
hip joints were analysed separately (SMD −0.32; 95% CI 
−0.37 to −0.27; P<0.001 and SMD −0.35; 95% CI −0.44 
to −0.26; P<0.001, respectively, and favouring non-obese 
patients) (figure 4). The results of individual studies not 
included in the pooled analyses are presented in table 3.
Association between obesity and postsurgical complications
The association between obesity and complications after 
joint arthroplasty was assessed by 40 studies including 
a total of 245 433 patients who underwent knee or hip 
arthroplasty. Of these, 17 presented enough data and 
were included in the meta-analyses.
The pooled results suggest that at short-term follow-up, 
non-obese participants are less likely to have postsurgical 
deep vein thrombosis (DVT) (OR 0.49; 95% CI 0.26 to 
0.91; P=0.024) when compared with obese participants 
(figure 5). A total of 13 studies were pooled (n=22 782) 
showing non-obese patients are also less likely to present 
any long-term (ie, ≥6 months) dislocation (OR 0.50; 
95% CI 0.31 to 0.80; P=0.003) and DVT (OR 0.58; 95% CI 
0.36 to 0.94; P=0.043). A non-significant difference 
between groups was observed between non-obese and 
obese participants for long-term revision surgery (OR 
0.66; 95% CI 0.34 to 1.28; P=0.217) (figure 5).
The pooled analysis on short-term postsurgical 
infection for hip replacement showed that non-obese 
patients are less likely to develop infections compared 
with obese participants (OR 0.33; 95% CI 0.19 to 0.59; 
P<0.001) (figure 6). For knee replacement, separate anal-
yses were conducted for studies comparing obese with 
non-obese participants and those comparing morbidly 
obese with non-obese participants (figure 7). The results 
Figure 1 Flow chart of search strategy and screening steps. Detailed steps of references screening process of results from 
database searches.
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suggest that non-obese patients are less likely to develop 
infections when compared with morbidly obese patients 
(OR 0.43; 95% CI 0.23 to 0.78; P=0.006). No association 
with postsurgical infection was observed when obese and 
non-obese participants were compared.
The overall pooled analysis for incidence of complica-
tions suggests that non-obese participants are less likely 
to present any postsurgical complication at the long-term 
follow-up (OR 0.56; 95% CI 0.42 to 0.75; P<0.001, respec-
tively). The results of individual studies not included in 
the pooled analyses are presented in table 4.
Association between physical activity participation and disability
The association between physical activity and disability was 
investigated by four studies73 75 76 79 or 1033 participants 
undergoing hip or knee arthroplasty. Included studies 
have not provided enough data to be pooled. The overall 
results from these four papers suggest that participants 
who practise more physical activity before the surgeries 
were more likely to experience less pain after either hip or 
knee surgery; however, the evidence regarding disability 
scores is still unclear with studies presenting contradic-
tory results. Table 5 presents the results of the individual 
studies.
DIsCussIOn
statement of principal findings
Our results suggest that following surgery, non-obese 
patients experience further reductions in both pain and 
disability after knee and hip arthroplasty when compared 
with obese patients, where obesity has been defined 
as having a BMI of 30 kg/m2 or over. These differences 
seemed to be more accentuated for knee pain outcomes 
following arthroplasty than for hip pain or disability 
outcomes. Non-obese participants also experienced 
significantly less postsurgical complications, including 
dislocation, DVT and infection especially following hip 
arthroplasty. Our analyses also demonstrate that obesity 
Figure 2 Fractional polynomial analysis for hip (A) and knee (B) disability scores and hip (C) and knee (D) pain scores over 
time. (A) Graphic representation of results from fractional polynomial analysis of disability scores evolution over time after hip 
surgeries. (B) Graphic representation of results from fractional polynomial analysis of disability scores evolution over time after 
knee surgeries. (C) Graphic representation of results from fractional polynomial analysis of pain scores evolution over time after 
hip surgeries. (D) Graphic representation of results from fractional polynomial analysis of pain scores evolution over time after 
knee surgeries.
group.bmj.com on March 4, 2018 - Published by http://bmjopen.bmj.com/Downloaded from 
38
11Pozzobon D, et al. BMJ Open 2018;8:e017689. doi:10.1136/bmjopen-2017-017689
Open Access
is a reliable predictor of complications after THA and 
TKA, in the short term after the procedure and at longer 
follow-ups. The evidence regarding preoperative phys-
ical activity remains unclear due to conflicting results 
of included studies, especially in terms of postoperative 
disability. The four included cohort studies, however, 
suggest that physical activity participation is associated 
with better pain outcomes following surgery.
Our results from the fractional polynomial analysis have 
also shown that all patients experienced an improvement 
in pain and disability after surgery. We also highlight that 
although non-obese patients experience further improve-
ments in pain and disability compared with obese partic-
ipants, both groups improved significantly following 
surgery as depicted in figure 2. The observed decrease in 
pain from baseline was approximately 70% at 6 months 
and 75% at 12 months, with decreases in disability of 55% 
at 12 months and 67% at 120 months. The interpretation 
of the postsurgical course of pain and disability, however, 
needs to be taken in the context of the inclusion criteria 
we have used in our review, given we have only included 
data from cohort studies that have assessed the role of 
obesity or physical activity participation on surgical 
outcomes.
strengths and weaknesses in relation to other studies, 
discussing particularly any differences in results
Our meta-analysis results regarding the association 
between obesity and postsurgical complications found 
that obese patients present higher complication rates 
than non-obese patients. These results are consis-
tent with the findings of previous systematic reviews 
of Hofstede et al,14 Samson et al15 and Liu et al.16 Our 
meta-analysis results regarding the association between 
obesity and postsurgery disability also agreed with 
the findings of Buirs et al13 and Samson et al,15 which 
found that obesity (defined as having BMI over 30 kg/
m2) was associated with worst postsurgical functional 
score. The only previous review which has performed 
a meta-analysis on the association between obesity 
and postarthroplasty pain or disability limited its 
inclusion criteria to hip joint.16 That review included 
a total of 15 studies in their meta-analysis and found 
that obesity increases the risk of postsurgical compli-
cations (RR 1.68; 95% CI 1.23 to 2.30; P=0.0004) and 
is associated with worse disability scores following 
surgery (MD −2.75; 95% CI −4.77 to −0.6; P=0.07). 
Our study has included 33 cohorts of hip arthro-
plasty participants in the qualitative analysis, 16 in the 
Figure 3 Pooled standardised mean difference (SMD) in pain at short term and long term after surgery between obese and 
non-obese patients. Results from meta-analysis of included studies presented as SMD of pain scores at short-term (<6 months) 
and long-term (≥6 months) follow-ups between non-obese and obese groups.
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meta-analyses, and confirms past findings that obesity 
is associated with worse outcomes in terms of disability 
and complications, and pain at both short-term and 
long-term periods following surgery. Hofstede et al14 
have also conducted a systematic review of the litera-
ture on preoperative predictors of surgical outcomes 
after hip replacement in patients with OA. Although 
those authors included 35 studies, only five studies 
investigated the effect of obesity on postsurgical pain, 
disability and quality of life.14 No meta-analysis was 
performed.
Implications for clinicians or policymakers
Our results have a direct impact on clinical practice as 
the results demonstrate that obese patients have a higher 
risk of complications and a poorer prognosis in terms 
of pain and disability postoperatively when compared 
with non-obese patients. These results also allude to the 
importance of identifying and implementing effective 
presurgical rehabilitation and weight loss approaches to 
optimise postsurgical outcomes and minimise harm to 
the patient. The importance of weight loss has been high-
lighted in international clinical guidelines on non-sur-
gical management of knee OA, for instance, given the 
pain and disability reductions observed following weight 
loss regimes.86 Past research also suggests there is a dose–
response relationship between weight loss and clinical 
outcome improvement. A recent completer-type anal-
ysis of 1383 participants with knee OA showed that a 
weight loss of 7.7% of body weight or more is associated 
with clinically important changes in pain and disability, 
as measured using the Knee Injury and Osteoarthritis 
Outcome Score (KOOS).87 This evidence reinforces the 
importance of presurgical weight loss programmes and 
strategies in order to optimise postsurgical recovery.
Figure 4 Pooled standardised mean difference (SMD) in disability at short term and long term after surgery between obese 
and non-obese patients. Results from meta-analysis of included studies presented as SMD of disability scores at short-term (<6 
months) and long-term (≥6 months) follow-ups between non-obese and obese groups.
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strengths and weaknesses of the study
The current review has included 62 cohort studies and a 
total of 256 481 participants and is the most comprehen-
sive systematic review on the topic to date. It is also the 
first review to use a quantitative approach to synthesise 
the results of pain, disability and surgical complications 
between non-obese and obese participants and consider 
the physical activity level of participants who underwent 
hip or knee arthroplasty due to OA. Our review has some 
limitations. The methodological quality of the included 
studies was in general poor. The most common method-
ological flaw among included cohorts was not controlling 
for confounding factors age, sex or BMI (32 studies, 
51%) followed by not using a representative sample 
(n=30 studies, 48%). Moreover, we have observed great 
variability of follow-up duration across studies, ranging 
from 2 weeks to 11 years. We have used a cut-off of 6 
months to define short-term follow-up (ie, <6 months) 
or long-term follow-up (ie, ≥6 months), but acknowledge 
that within each follow-up category there was substantial 
variation in the duration of follow-up across studies.
Between-study heterogeneity has also been observed in 
some of the pooled analysis for obesity presented in this 
review. A potential source of between-study heterogeneity 
Figure 5 Pooled association between complications and obesity at short-term and long-term follow-ups. Results from meta-
analysis of included studies presented as incidence of complications at short-term (<6 months) and long-term (≥6 months) 
follow-ups between non-obese and obese groups. DVT, deep vein thrombosis.
Figure 6 Pooled association between postsurgical infections and obesity for hip surgery. Results from meta-analysis of 
included studies presented as incidence of infections after hip surgery between non-obese and obese groups.
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includes the variability in the definition of obesity cate-
gories across studies. Although obesity was assessed using 
BMI scores in all studies, some studies have used only 
two obesity groups (ie, obese or non-obese) while others 
used several categories including underweight, normal or 
overweight, obese and morbidly obese. These needed to 
be combined for some of our pooled analyses.
Another potential source of between-study hetero-
geneity across is the difference in surgical procedures 
used across studies. For instance, in the pooled analysis 
of risk of postsurgical DVT and obesity, while Kandil et 
al54 performed unicompartmental knee arthroplasties, 
Friedman et al42 performed total arthroplasties on both 
hip and knee joints. That discrepancy might explain the 
different results reported by these two studies (figure 5). 
Likewise, the mean physical activity load reported by the 
included studies varied substantially, ranging from low to 
high frequency of participation in low and high-impact 
activities. This should be taken into consideration when 
interpreting the physical activity results.
COnClusIOn
Our results have shown that obese patients undergoing 
hip or knee arthroplasty due to OA have worse outcomes 
in terms of pain and complications when compared with 
non-obese patients, with differences more accentuated 
for patients with knee OA. Likewise, obese patients will 
have worse surgical outcomes in terms of disability, but 
only at long-term follow-ups. It is still unclear whether 
presurgical physical activity participation has an impact 
on surgical outcomes. However, we acknowledge that 
the health benefits of physical activity participation for 
patients with knee and hip OA are multiple and reach 
beyond those considered in this review.
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APPENDIX 1 
MEDLINE search strategy terms used: 
 
1 obesity.mp. or exp Obesity/ or exp Obesity, Abdominal/ 197.941 
2 Physical Activity.mp. or exp Motor Activity/ 231.947 
3 sedentar$.mp. 19.058 
4 
(time adj5 sitting).mp. [mp=title, abstract, original title, name of substance 
word, subject heading word, keyword heading word, protocol supplementary 
concept word, rare disease supplementary concept word, unique identifier] 
688 
5 1 or 2 or 3 or 4 414.967 
6 
exp Postoperative Complications/ or exp Hip Prosthesis/ or exp Arthroplasty, 
Replacement, Hip/ or hip arthroplasty.mp. or exp Osteoarthritis, Hip/ or exp 
Hip Joint/ 
469.282 
7 knee arthroplasty.mp. or exp Arthroplasty, Replacement, Knee/ 17.365 
8 exp Elective Surgical Procedures/ or elective surgery.mp. 14.058 
9 osteoarthritis.mp. or exp Osteoarthritis, Hip/ or exp Osteoarthritis/ or exp Osteoarthritis, Knee/ 55.493 
10 exp Osteonecrosis/ or Osteonecrosis.mp. 13.961 
11 arthroplasty.mp. or exp Arthroplasty, Replacement, Knee/ or exp Arthroplasty, Replacement/ or exp Arthroplasty/ or exp Arthroplasty, Replacement, Hip/ 53.979 
12 6 or 7 or 8 or 9 or 10 or 11 546.616 
13 exp Cohort Studies/ or cohort.mp. 1.526.984 
14 incidence.mp. or exp Incidence/ 587.274 
15 exp Follow-Up Studies/ or follow-up.mp. 912.064 
16 prognosis.mp. or exp Prognosis/ 1.273.869 
17 exp Prognosis/ or predictors.mp. 1.258.014 
18 exp Time Factors/ or course.mp. 1.403.404 
19 exp Survival Analysis/ or exp Survival/ or exp Survival Rate/ or survival.mp. 843.771 
20 logistic.mp. 198.801 
21 cox.mp. 84.820 
22 life table.mp. or exp Life Tables/ 18.098 
23 log rank.mp. or exp Follow-Up Studies/ 533.280 
24 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 4.460.132 
25 Animals/ 5.495.334 
26 exp Editorial/ or editorial.mp. 376.114 
27 case report.mp. or exp Case Reports/ 1.754.352 
28 letter.mp. or exp Letter/ 895.420 
29 25 or 26 or 27 or 28 8.184.015 
30 5 and 12 and 24 7.601 
31 30 not 29 6.869 
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Significance: Sex was not associated with the prevalence of low back pain at the individual level or 
when partially controlling for the role of genetics and early shared environment. These findings 
question previous research that shows higher prevalence of low back pain among women. 
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Abstract 
Objective: To assess the association between sex and the lifetime prevalence of low back pain by 
controlling for a range of confounders by using a co-twin control design and opposite-sex dizygotic 
(DZ) twin pairs from Australia, USA, and Spain. 
Methods: Using a co-twin control design and opposite-sex dizygotic (DZ) twin pairs from Australia, 
USA, and Spain. 
Results: A total of 1,977 twins from three different twin registries were included in the analyses. Sex 
was not associated with prevalence of low back pain in neither co-twin control analyses: unadjusted 
(OR 0.85; 95% CI 0.68 to 1.06, p=0.15) and adjusted (OR 1.02; 95% CI 0.77 to 1.36, p=0.9). Based on 
the Spanish data, men were less likely to seek care (OR 0.47; 95% CI 0.27 to 0.79, p=0.005) or to 
report activity limitation (OR 0.61; 95% CI 0.37 to 0.99, p=0.05) compared with women. When 
pooling data from 3 twin registries, no difference in prevalence of low back pain was found between 
sexes (OR 0.93; 95% CI 0.76 to 1.15, p=0.512). There were no differences between sexes in pain 
intensity. 
Conclusions: Although men are less likely to seek care and report activity limitations due to low back 
pain, the overall prevalence of low back pain is not associated with sex when genetic and early 
environmental factors are partially controlled for. Our analyses challenge previous findings from 
cross-sectional studies that low back pain is more prevalent among women. Future studies including 
larger multicultural samples of opposite-sex twin pairs should be conducted to further assess these 
results. 
Keywords: Sex differences, genetics, early shared environment, low back pain, twin registry. 
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Introduction 
With approximately 80% of the adult population experiencing an episode at some point in their lives 
[1, 2], low back pain is currently the highest contributor to disability worldwide [3], substantially 
impacting on individuals [4] and society [5]. A recent systematic review of 28 studies with data 
available from 488,000 participants assessed the global prevalence of chronic low back pain and 
found it to be 50% higher among women compared with men [6]. However, data on the point 
prevalence of low back pain from a global study found the opposite with the prevalence of low back 
pain being higher for men than for women [7]. Sex differences also seem to be associated with 
health care behaviour, given that women are 67% more likely to seek medical help for low back pain 
than men [8]. This difference in behaviour could influence reports regarding prevalence and health 
care use due to low back pain. 
The role of different risk factors for low back pain and their distribution between sexes are also likely 
to influence the prevalence of this condition across sexes. For instance, smoking has been associated 
with higher risk of developing low back pain [9], and the prevalence of smoking is known to be 
higher for males [10]. Past research has identified numerous risk factors for low back pain, including 
the contribution of genetics [11]. A recent systematic review of 27 studies using twin samples found 
evidence that genetics (or at least factors shared by twins) plays an important role in explain the 
differences between people in the same population in their susceptibility to low back pain [11]. No 
previous study of sex differences in prevalence, however, has controlled for the role of genetics and 
early shared environment. This is a major limitation and has the potential to have contributed to 
inconsistencies between results, given the strong influence genetics and the early shared 
environment could play on the onset of low back pain [12, 13]. 
An early environment shared by family members has also been found to impact on the development 
of conditions, including low back pain [11]. Parenting styles as well as parents’ health lifestyle 
behaviours, including healthy eating [14] and physical activity engagement [15], are associated with 
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back pain in the offspring and can be used to identify those at higher risk of developing chronic back 
problems. Early shared environmental factors, including family income, educational level, and 
physical activity habits are rarely captured in traditional cohort studies addressing sex and low back 
pain, but can influence the relationship between exposure (i.e. sex) and outcome (i.e. low back pain) 
[11, 16]. 
One effective method to control for genetic and early shared environmental confounding on the 
prevalence of conditions or traits is the co-twin control design. Monozygotic twins (MZ) share 100% 
of their genes and dizygotic twins (DZ), which can be same-sex or opposite-sex, share on average 
50% of their genes. In addition to genes, twins, regardless of zygosity, are also exposed to a similar 
early-life shared environment, and these factors can be controlled for in co-twin control studies. This 
design also allows for the comparison of individuals who share total or part of their genotype and 
have a very similar early environment in childhood, but differ regarding the exposure factor (i.e. sex) 
or the presence of the condition of interest (i.e. low back pain). 
The co-twin control design applied to opposite sex twin pairs is a robust and what appears to be a 
novel way to control for the association of sex on the onset of different conditions. Although 
opposite-sex twin pairs have been used in some twin studies to investigate the association between 
sex and health conditions such as eating disorders [17], depression [18] and cancer [19], they have 
not used a within-pair simple comparison and have not directly addressed the question of whether 
the disease prevalence differs by sex within-pairs. The main advantage of employing a co-twin 
control design is the ability to control, at least to some extent, for a wide range of potentially 
confounding factors that could interfere with the association between exposure and outcome. To 
our knowledge, there is no previous research using this design to evaluate the association between 
sex and the prevalence of low back pain by matching in part for genetic and early shared 
environmental risk factors. 
53
Association between Sex and Low Back Pain in twins 
We have set up a consortium of twin registries with data from opposite sex DZ twin pairs living in 
Australia, Spain, and USA to investigate sex differences in low back pain prevalence. By providing 
empirical data about the role of sex on the prevalence of low back pain, clinical practice could be 
more focused on interventions considering the morphological and behavioural differences between 
sexes. 
The main aim of this study was to assess the association between sex and lifetime prevalence of low 
back pain. Secondary aim of this study was to assess the association between sex and health care 
seek, activity limitation and pain intensity due to low back pain. We explore the influence of a range 
of confounders, including genetic and early shared environmental factors, by using a co-twin control 
design and opposite-sex dizygotic (DZ) twin pairs from Australia, Spain, and USA. 
 
Materials and Methods 
Design 
This study employed a cross-sectional, co-twin control design of opposite sex twin pairs. We used 
data from all DZ opposite-sex twins available from a consortium of twin registries from Spain (Murcia 
Twin Registry), United States (Washington State Twin Registry), and Australia (Twins Research 
Australia). A brief description of each registry is provided below. 
 
Twins Research Australia (TRA) 
Study Sample and Data Collection 
This is a volunteer registry of Australian twin pairs established in the late 1970s and includes over 
40,000 pairs. From this number, 2,660 participants answered the low back pain question on the 
health and lifestyle section of the questionnaire and were screened for the study’s inclusion criteria, 
resulting in 119 participants able to be included in our analyses. Information regarding Twins 
Research Australia’s (formerly known as the Australian Twin Registry) characteristics and 
recruitment procedures can be found elsewhere [20]. 
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Murcia Twin Registry (MTR) 
Study Sample and Data Collection 
This is a population-based twin registry of twins born between 1940 and 1966 in the region of 
Murcia, Spain. Information regarding the MTR characteristics and recruitment procedures can be 
found elsewhere [21]. All recruitment and data collection procedures were approved by the 
University of Murcia Ethics Committee and the MTR Committee, and informed consent was obtained 
from all participants. 
 
Washington State Twin Registry (WSTR) 
Study Sample and Data Collection 
This is a community-based twin registry established in 2002 in the state of Washington, USA. 
Information regarding the WSTR characteristics and recruitment procedures can be found 
elsewhere[22]. All recruitment and data collection procedures were approved by the University of 
Washington and Washington State University Institutional Boards before recruitment, and informed 
consent was obtained from all participants. 
 
Assessment of outcome across registries 
In all three registries, the lifetime prevalence of low back pain diagnosed by a doctor or other health 
care professional was assessed through specific questions in their assessment booklets. As expected, 
there were some differences in the way prevalence of low back pain was ascertained across 
registries. We therefore chose the measure that was most similar across them: “Has as doctor ever, 
or in the last years, diagnosed you with chronic low back pain/back problems?”. In addition to the 
previous question, information about low back pain related phenotypes was selected, in the MTR, 
from available data gathered in a different data collection wave. Hence, lifetime prevalence of care 
seeking due to low back pain was further assessed through a specific question:“Have you ever 
sought medical help due to low back pain?”, with activity limitation due to low back pain being 
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assessed through the question: “Has this pain been intense to the point of limiting your daily 
activities or changing your daily routine for over one day?” The dichotomous answers (yes/no) to the 
questions were extracted and used in our analysis. The WSTR data used were collected between 
2009 and 2013 and the TRA data used were extracted from the updated 2016 version of the registry. 
Data on lifetime prevalence of low back pain from the MTR were extracted from the 2009 data 
collection wave. Pain intensity was assessed through a visual scale ranging from 0 to 10, were 0 
means “no pain” and 10 means “unbearable pain”. We further categorised scores below 7 as “mild”, 
scores between 7 and 8 as “moderate” and those above 8 as “severe pain”. These specific cut-off 
points were defined based on the percentile distribution of the pain ratings reported by the 
participants. Participants in the Upper Quartile of the distribution reported pain of over 8 points (out 
of 10). The Second Upper Quartile included participants reporting pain of intensity between 7 and 8 
points, and the Second Lower Quartile of the sample reported pain of between 5 and 7 points. Data 
on pain intensity, care seeking and activity limitation due to low back pain was only available, for the 
MTR, from the 2013 data collection wave. Although research showing that dichotomizing continuous 
variables reduces the statistical power of the analyses, in this paper dichotomizing the sample 
according to the presence of LBP is still the best way to categorize participants into symptomatic and 
asymptomatic groups. This approach allows us to compare participants following the presence of the 
symptom of interest (i.e. low back pain). This, added to the bigger sample size we had, tends to 
minimize any detrimental effect of the dichotomization [23]. 
 
Assessment of potential confounding factors across registries 
Potential confounding variables were selected based on data availability and on the literature 
investigating the effect of health and lifestyle factors on low back pain. Recent systematic reviews 
have shown that factors such as smoking, physical activity participation, symptoms of anxiety and 
depression, and obesity are significantly associated with low back pain [11, 24-26]. These variables 
therefore have been selected and tested as potential confounders in our analyses. The variables, 
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questions, and answers extracted from all registries and the pooling strategy are described in table 
1. Data on smoking was dichotomized into: any past smoking history and/or current smoker and 
never smoked. Depression and anxiety symptoms were dichotomised into “no” or “yes” according to 
the presence of symptoms and medical diagnosis following the participants’ answers to a specific 
question on MTR “Have you ever suffered from a major health condition in any point in life? In the 
past few years? Was it diagnosed by a doctor?”, and the question “Has a medical doctor, dentist, or 
other health care professional ever diagnosed you with depression?” in the WSTR and TRA. Body 
mass index (BMI) was calculated based on the height and weight reported by participants and was 
analysed as a continuous variable. We conducted an initial analysis on data from each registry to find 
the similar variables across registries in order to pool all the data into harmonised variables to be 
analysed. We pooled the variables regarding low back pain lifetime prevalence, depression 
symptoms, and smoking. We then conducted univariate analysis between the potential confounders 
(i.e. BMI, smoking, depression/anxiety symptoms, and physical activity), sex and low back pain on 
data from the merged sample to identify the covariates that needed to be included in the 
multivariate models. 
 
Statistical Analysis 
All analyses were conducted in two stages: (I) total sample analysis of all individual twins and (II) co-
twin control analysis. Both stages were conducted with and without adjustments for potential 
confounding factors, generating 4 different models. Sex was considered the exposure factor (with 
female being categorized as the reference sex) and low back pain related outcomes were considered 
as the outcome variables, namely: lifetime prevalence of low back pain, care seeking due to low back 
pain, and self-reported activity limitation due to low back pain. All outcome variables were 
categorized as dichotomous variables, with the answer “yes” meaning presence and “no” meaning 
absence of the condition. 
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To investigate which of the covariates would be included in the multivariate analysis as confounders, 
the association between each covariate and the outcomes was assessed using univariate logistic 
regression models considering all the subjects individually. Covariates which showed a significant 
association (p≤0.2) with both exposure and outcome of interest were included in multivariate 
analyses of the total sample and also the co-twin control analysis [24, 27]. The additional data on 
low back pain from the 2013 wave of the MTR allowed us to conduct further analysis to assess the 
association between sex and the prevalence of care seeking, activity limitation, and pain intensity 
considering only twin pairs discordant for each outcome variable. Data analyses were performed 
using STATA statistical software (version 14.0). 
 
Total sample analysis 
For this analysis, all DZ opposite-sex twins were included, regardless of concordance or discordance 
status for low back pain, with twins being analysed as individuals rather than pairs. In this analysis 
we used logistic regression models adjusted for BMI, smoking and depression to assess the 
association between sex and low back pain within the whole sample, considering each participant 
individually and, therefore, the effects of genetics and early shared environmental factors were not 
controlled for. 
 
Due to data availability, we conducted further analyses only on MTR data to assess the association 
between sex and the prevalence of care seeking, activity limitation, and pain intensity considering all 
twins in the database without adjustment, and adjusting for those confounders found to be relevant. 
 
Co-twin Control analysis 
To control for genetics and early shared environmental factors as confounders in the association 
between sex and low back pain, we performed a within-pair twin analysis on all complete pairs of 
opposite sex DZ twins using conditional logistic regression analysis where only one of the twins 
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reported low back pain. The relationship between two variables (i.e. sex and prevalence of low back 
pain) is possibly more consistent with a direct causal path if the magnitude of the association 
between them remains unaltered or increases from the total sample analysis (no adjustment for 
genetics or early shared environment) to a co-twin control analysis (when the early shared 
environment and approximately 50% of genetics are controlled for) [28]. 
 
Table 1: Description of studied variables according to each twin registry. 
 
Results 
Sample characteristics 
Of the 5,876 individual twins available from the three registries, a total of 1,977 twins had complete 
answers to all the variables of interest and were included in this study, being analysed both as a total 
sample and separately for each twin registry. The lifetime prevalence of low back pain in the total 
sample was 33.4%. The mean age in the total sample was 48.2 years (SD 16), the mean BMI was 26.5 
kg/m2 (SD 5.8), 44.9% of the sample were either current smokers or reported some history of any 
smoking, 22% reported symptoms of depression or anxiety, and 50.5% of the total sample was 
comprised of females. The characteristics of participants for each registry and for the merged 
sample are described in table 2. 
 
Potential confounders 
The univariate models identified BMI, smoking, and depression/anxiety symptoms as possible 
confounders for the association between sex and low back pain and therefore were included in the 
merged sample multivariate models. Data on physical activity participation was available from the 
MTR and WSTR. However, the questions used and variables available were too discrepant to be 
pooled in the analysis, and therefore this variable was not included in the multivariate models. Age 
was not found to be a significant confounder, therefore it was not included in the analyses. 
59
Association between Sex and Low Back Pain in twins 
Association between sex and low back pain 
The multivariate analysis showed that sex was not associated with the prevalence of low back pain 
either without (OR 0.89; 95% CI 0.74 to 1.07, p=0.227) or with adjustment for age, BMI, smoking, 
and depression and anxiety symptoms (OR 0.93; 95% CI 0.76 to 1.15, p=0.512). The co-twin control 
analysis in the total merged sample did not reveal a significant association between sex and low back 
pain both without (OR 0.85; 95% CI 0.68 to 1.06, p=0.151) or with adjustments (OR 1.02; 95% CI 0.77 
to 1.36, p=0.871). When conducting separate analyses for each registry, sex was associated with the 
lifetime prevalence of LBP in all analyses only in the MTR registry. Results for the total merged 
sample and separate analyses for each registry are presented in table 3. 
 
Association between sex and care seeking, activity limitation, and pain intensity in the MTR 
When performing the secondary exploratory unadjusted analysis on the MTR data, results showed 
that men were less likely to seek care than women when considering both the total sample (OR 0.39; 
95% CI 0.26 to 0.57, p<0.001) or the co-twin control analysis (OR 0.37; 95% CI 0.24 to 0.58, p<0.001). 
When the models were adjusted for age, BMI, smoking and depression and anxiety symptoms, 
similar results were found, and men were less likely to seek care due to low back pain than women 
in the total (OR 0.44; 95% CI 0.29 to 0.67, p<0.001), and in the co-twin control analysis (OR 0.47; 95% 
CI 0.27 to 0.79, p=0.005) (table 4). 
 
Men were also less likely to report activity limitation than women in the total sample and co-twin 
control analyses (OR 0.59; 95% CI 0.40 to 0.87, p=0.008; and OR 0.56; 95% CI 0.35 to 0.88, p=0.012, 
respectively). Models adjusted for age, BMI, smoking and depression and anxiety symptoms showed 
similar results, and men were less likely to report activity limitation due to low back pain than 
women in the total (OR 0.64; 95% CI 0.42 to 0.98, p=0.039), and co-twin control analyses (OR 0.61; 
95% CI 0.37 to 0.99, p=0.047) (table 4). 
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The results of unadjusted analyses in the total sample assessing pain intensity showed no association 
between sex and mild (ie.e Second Lower quartile) or moderate (i.e. Second Upper quartile) pain 
scores (unadjusted model OR 1.09; 95% CI 0.37 to 3.25, p=0.870 and OR 1.04; 95% CI 0.29 to 3.74, 
p=0.948, respectively). Similar results were observed in the adjusted analyses models including 
participants in the Second Lower and Second Upper Quartiles of pain intensity distribution (OR 1.12; 
95% CI 0.42 to 2.99, p=0.808 and OR 1.04; 95% CI 0.31 to 3.49, p=0.948, respectively). Due to the 
small sample analyses were not possible for the co-twin control analyses of the Second Lower 
quartile and the analyses done on the Second Upper quartiles returned unreliable results. Similar 
results were observed considering the Upper Quartile of pain intensity distribution (unadjusted 
model OR 0.86; 95% CI 0.29 to 2.59, p=0.802; adjusted model OR 0.82; 95% CI 0.31 to 2.22; p=0.704). 
Due to the small sample analyses were not possible for the co-twin control analyses. Detailed results 
for the MTR analyses of sex and pain intensity are presented in table 4. 
 
Table 2:Characteristics of participants presented as mean (SD) or number of respondents (%), 
stratified by registry and sex. 
 
Table 3: Association between sex and lifetime prevalence of low back pain (LBP). 
 
Table 4: Association between sex and low back pain (LBP) as care seeking, activity 
limitation, and pain intensity in the Murcia Twin Registry. 
 
Discussion 
Our results indicate that sex is not associated with low back pain prevalence. There was no 
significant association between sex and prevalence of low back pain on the merged sample, however 
this association was statistically significant on the MTR sample alone. Also, no association was 
observed when data were analysed using all twins as participants, or when we conducted the co-
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twin control analyses adjusting for genetics and early shared environment. Some differences on the 
association between sex and the lifetime prevalence of low back pain were noticed when 
considering registries separately; this could be explained by the different prevalence of smoking and 
the presence of symptoms of anxiety and depression among registries. Our secondary analyses of 
care seeking, activity limitation, and pain intensity using only data from the MTR showed that men 
are approximately 50% less likely to seek medical care or report daily activity limitations due to low 
back pain than women (table 4). 
 
Twin studies are an effective method to assess complex conditions, such as low back pain, due to the 
role of multiple environmental, age, and genetic influences that are similar to both participants 
within each twin pair [29]. Because the actual factors that might contribute to the onset of low back 
pain are not yet clearly identified [30], the twin design is ideal due to the possibility of controlling for 
measured and unmeasured factors. To our knowledge this is the first study to use the opposite DZ 
co-twin control design to assess the effect of sex on the prevalence of low back pain. Another 
strength of our study is the integration of three registries from different countries in different 
continents. This brings diversity and allows our results to be more broadly generalisable. 
 
One weakness of our study is the relative limited number of participants in the co-twin control 
analysis. This is due to the fact that participants need to fulfil a set of criteria, namely: the twin pair 
must be DZ, of opposite-sex, and also be discordant for the outcomes of interest. Although some of 
the estimates observed were of significant magnitude (e.g. analysis of care seeking and activity 
limitation in the MTR data), these analyses were likely to be underpowered due to limited sample 
size. Another limitation is the discrepancies among the questionnaires regarding the definitions of 
low back pain and physical activity; however, we considered the questionnaires similar enough to be 
pooled. 
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Our results contradict those of two recent systematic reviews [6, 31]. The first review was published 
in 2015 and included 25 cross-sectional and 3 cohort studies. The authors found the prevalence of 
chronic low back pain was 50% higher in women [6], compared to men. The second review was 
published in 2016 and included 98 studies (n=772,927), also demonstrated that women are more 
likely to report chronic low back pain, compared to men (prevalence rates between 1.14 and 1.31, 
depending on the age group) [31]. 
 
Both reviews used data from participants with a broad age range; the first review including subjects 
as young as 16 years of age and the later review including children. Although our analyses also 
included participants as young as 18 years of age, the mean age of our combined cohort was 48.2 
years; with 75% of our subjects being older than 40 years. The difference in mean age of the cohorts, 
the lack of control for the role of genetics and early shared environment; and the lack of statistical 
adjustment for main confounders, including BMI, smoking and symptoms of depression and anxiety, 
may explain the difference in results across the studies. 
 
The results from the secondary analyses on the MTR sample suggests men are less likely to seek care 
for low back pain, even though they seem to experience the condition at similar intensity compared 
to women. Our results are in line with past research also showing women are more likely to seek 
care due to low back pain [8]. These findings could be explained by possible behavioural and cultural 
differences between sex, with men feeling less comfortable with seeking care or less concerned with 
the impact of pain on their daily activities, compared to women. Past research has shown that low 
back pain is often associated with fear of social isolation including loss of employment and 
subsequent financial struggle [32]. The social stigma surrounding low back could impact genders 
differently, depending on the roles men and women have in society. It is important to highlight that 
these findings are only based on data from the Murcia Twin Registry, given the other participating 
data sources did not provide data on care seeking for low back pain. 
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This is the first paper to adjust for the role of genetics and early shared environment on the 
differences between sexes regarding the prevalence of low back pain. This topic demands further 
research as genetics [33, 34] and early shared environment [11] have already been associated to the 
low back pain onset, nevertheless the nature of association is still uncertain. Recent research also 
points to the concept that educational level and physical activity are generally associated with low 
back pain, however, when controlling for genetics and early shared environment these associations 
tend to fade [26, 35]. Together, these results suggest that genetics and early shared environment 
play a role on the development of low back pain, and on the relationship between low back pain and 
other important factors. 
 
In our co-twin control analyses, only twin pairs who were discordant for the outcome (low back 
prevalence) were included, therefore our sample is only representative of opposite-sex twin pairs 
who are discordant for LBP and the interpretations of our findings have followed accordingly. The 
questionnaires used by the registries did not have data on sex-specific socialization, although we 
have plans to conduct other analyses, in the future, in datasets where more unique environmental 
measured factors could be included in our models. 
 
Future research should use more robust assessments of care seeking using data linkage with 
routinely collected data on prescribed medications and healthcare visits to investigate if women 
indeed have more limitations and seek care more often due to low back pain or if they just are more 
likely to report these limitations, which could introduce bias in studies of this type. Future research 
should also be based on standardized questionnaires among twin registries around the world in 
order to make the merging process more reliable, which will allow researchers to merge data from 
different registries reaching bigger sample sizes and minimizing the influence of behavioural 
differences among the included subjects. 
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Conclusion 
Sex is not associated with the prevalence of low back pain regardless if genetics and the early shared 
environment are controlled for or not. Men are, however, less likely to seek care and report activity 
limitation due to low back pain, compared to women, even when genetics and early shared 
environmental factors are controlled for. 
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Table 1: Description of studied variables according to each twin registry. 
Variable  Registry Question Answers (tick box) 
Low Back 
Pain 
Twins 
Research 
Australia 
Has a doctor ever diagnosed you with 
any of the following conditions? 
Back pain / back problems ( yes/ 
no) 
Murcia Twin 
Registry 
Have you ever suffered from a major 
health condition in any point in life? In 
the past few years? Was it diagnosed 
by a doctor? 
Chronic spinal pain (low back) 
1=Yes / 2=No 
Washington 
State Twin 
Registry 
Has a medical doctor, dentist, or other 
health care professional ever 
diagnosed you with...? 
Low back pain (yes / no) 
Depression 
Twins 
Research 
Australia 
Has a doctor ever diagnosed you with 
any of the following conditions? 
Depression ( yes/ no) 
Murcia Twin 
Registry 
Have you ever suffered from a major 
health condition in any point in life? In 
the past few years? Was it diagnosed 
by a doctor? 
Depression, anxiety or other 
mental issues 1=Yes / 2=No 
Washington 
State Twin 
Registry 
Has a medical doctor, dentist, or other 
health care professional ever 
diagnosed you with...? 
Depression (yes / no) 
Smoking  
Twins 
Research 
Australia 
Has there been a time when you 
smoke cigarretes regularly? 
Yes / No / Don't know / Prefer 
not to answer 
Murcia Twin 
Registry 
Have you ever smoked? 
1.- I never smoked / 2.- Have 
tried but no smokers/Very 
occasionally / 3.- Current smokers 
/ 4.- Ex- smokers / 5.- Smoker 
some time. No info on current 
smoking a 
Washington 
State Twin 
Registry 
Have you ever smoked at least 100 
cigarretes in your entire life? 
Yes / No 
aAnswers on smoking from the Murcia Twin Registry were grouped as: no smoker (1 and 2) and 
smoker (3, 4 and 5). 
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Table 2: Characteristics of participants presented as mean (SD) or number of respondents (%), stratified by registry and sex. 
Variables Merged Sample Twins Research Australia 
Washington State Twin 
Registry 
Murcia Twin Registry 
 
Female Male Female Male Female Male Female Male 
Sample (%) 1,002 (50.7) 975 (49.3) 119 (50) 119 (50) 530 (50) 530 (50) 353 (52) 326 (48) 
Age (SD) 48.2 (16.1) 48 (16.2) 51.8 (15.2) 51.8 (15.2) 42.2 (18) 42.2 (17.9) 56.1 (6.9) 56.2 (7.1) 
BMI (SD) 26.3 (6.5) 26.7 (4.9) 26.4 (10.9) 26.9 (4.6) 25.9 (6.3) 26.0 (5.3) 26.8 (4.4) 27.9 (4.2) 
Smoking (%) 340 (17.2) 479 (24.2) 8 (3.4) 9 (3.8) 176 (16.6) 226 (21.3) 156 (23) 224 (33) 
Depression/ 
283 (14.3) 138 (7) 21 (8.8) 17 (7.1) 129 (12.2) 71 (6.7) 133 (19.6) 50 (4) 
Anxiety (%) 
LBP (%) 305 (15.4) 275 (13.9) 37 (15.5) 45 (18.9) 160 (15.1) 166 (15.7) 108 (15.9) 64 (9.4) 
BMI = body mass index; LBP = low back pain; Smoking = past and current smokers. 
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Table 3: Association between sex and lifetime prevalence of low back pain (LBP). 
 
Merged Registries Twins Research Australia 
Washington State Twin 
Registry 
Murcia Twin Registry 
Model OR (95 % CI) N OR (95 % CI) N OR (95 % CI) N OR (95 % CI) N 
Prevalence analysisa 
        
Unadjusted 0.89 (0.74 to 1.07) 1,883 1.35 (0.80 to 2.26) 238 1.06 (0.83 to 1.35) 993 0.54 (0.38 to 0.78) 652 
Adjustedb 0.93 (0.76 to 1.15) 1,692 1.56 (0.62 to 3.92) 88 1.11 (0.85 to 1.44) 989 0.59 (0.39 to 0.91) 615 
Co-twin control analysisc 
        
Unadjusted 0.85 (0.68 to 1.06) 606 1.38 (0.79 to 2.42) 100 1.05 (0.77 to 1.42) 336 0.39 (0.24 to 0.63) 170 
Adjustedb 1.02 (0.77 to 1.36) 506 11.80 (0.27 to 511.91) 18 1.23 (0.88 to 1.73) 334 0.49 (0.25 to 0.94) 154 
a Prevalence analysis: All twins included. b Adjusted for BMI, smoking and depression. Bold denotes significance at the 0.05 level. c Co-twin 
control analysis: Only twin pairs discordant for low back pain were included. 
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Table 4: Association between sex and low back pain (LBP) as care seeking, activity limitation, and pain intensity in the Murcia Twin Registry. 
 
Care seeking Activity limitation 
Second Lower Quartile 
LBP intensity 
Second Upper Quartile 
LBP intensity 
Upper quartile  
LBP intensity 
Model OR (95 % CI) N OR (95 % CI) N OR (95 % CI) N OR (95 % CI) N OR (95 % CI) N 
Prevalence analysisa           
Unadjusted 0.39 (0.26 to 0.57) 476 0.59 (0.40 to 0.87) 476 1.09 (0.37 to 3.25) 163 1.04 (0.29 to 3.74) 54 0.86 (0.29 to 2.59) 124 
Adjustedb 0.44 (0.29 to 0.67) 474 0.64 (0.42 to 0.98) 474 1.12 (0.43to 2.98) 163 1.04 (0.31 to 3.49) 54 0.82 (0.31 to 2.22) 124 
Co-twin control 
analysisc 
    
  
    
Unadjusted 0.37 (0.24 to 0.58) 198 0.56 (0.35 to 0.88) 162 ---d  0.50 (0.04 to 5.51) 6 ---d -- 
Adjustedb 0.47 (0.27 to 0.79) 196 0.61 (0.37 to 0.99) 162 ---d  1.00 (0.06 to 15.99) 6 ---d -- 
a Prevalence analysis: All twins included. b Adjusted for BMI, smoking and depression. Bold denotes significance at the 0.05 level. c Co-twin control 
analysis: Only twin pairs discordant for low back pain (LBP) were included. d These analyses were not performed due to limited number of 
participants. 
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Abstract
Background and objective
Approximately half of the population will experience either low back pain or neck pain, at
some point in their lives. Previous studies suggest that people with diabetes are more likely to
present with chronic somatic pain, including shoulder, knee and spinal pain. This study aimed
to systematically review and appraise the literature to explore the magnitude as well as the
nature of the association between diabetes and back, neck, or spinal (back and neck) pain.
Databases and data treatment
A systematic search was performed using the Medline, CINAHL, EMBASE, and Web of Sci-
ence electronic databases. Studies which assessed the association between diabetes and
back or neck pain outcomes, in participants older than 18 years of age were included. Two
independent reviewers extracted data on the incidence of pain and reported associations.
Results
Eight studies were included in the meta-analyses. Meta-analyses showed that people with
diabetes are more likely to report low back pain [5 studies; n: 131,431; odds ratio (OR): 1.35;
95% Confidence Interval (CI): 1.20 to 1.52; p<0.001] and neck pain (2 studies; n: 6,560; OR:
1.24; 95% CI: 1.05 to 1.47; p = 0.01) compared to those without diabetes. Results from one
longitudinal cohort study suggested that diabetes is not associated with the risk of develop-
ing future neck, low back or spinal pain.
Conclusions
Diabetes is associated with low back and neck individually, and spinal pain. The longitudinal
analysis showed no association between the conditions. Our results suggest that diabetes
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co-exists with back pain; however, a direct causal link between diabetes and back pain was
not established.
Systematic review registration
PROSPERO registration CRD42016050738.
Introduction
Low back and neck pain are commonly reported musculoskeletal disorders. Approximately
80% of adults will experience low back pain, and 47% will experience neck pain, at some point
in their lives [1]. Similarly, diabetes mellitus is an increasingly prevalent chronic condition,
with an estimated 382 million people living with this metabolic disease around the world [2].
Previous data suggest people with diabetes are more likely to present with chronic somatic
pain, including painful diabetic peripheral neuropathy [3]. For example, a recent cohort study
with more than 39,000 participants found that people with diabetes have a significantly higher
risk of developing musculoskeletal pain, including back and neck pain [4]. The burden of hav-
ing both diabetes and musculoskeletal pain, which results in higher levels of pain, disability
and psychological distress, is substantially more compared to having just one of the conditions
[3, 5].
However, the link between musculoskeletal pain and diabetes remains unclear. Past
research suggests that having diabetes may predispose patients to develop lumbar disc disease
as a result of secondary, diabetes-related microangiopathy of the lumbar disks [6]. Addition-
ally, the accumulation of advanced glycation end-products (AGE) in animal models of diabetes
is linked to increased rates of catabolic reactions in intervertebral disc cells, reduced disc
hydration and increased disc tissue stiffness, which leads to intervertebral disc degeneration
[7]. However, these findings have not been confirmed in human studies.
Diabetes and back pain also share common risk factors such as obesity [8], physical inactiv-
ity [9, 10]; or predisposing factors such as low-grade systemic inflammation [11, 12]. People
with a higher body mass index (>35) at a younger age (i.e. 18 years old) are over nine times
more likely to develop diabetes later in life [13]. Likewise, obesity is an independent predictor
of severe low back pain in the general population [14]. People with diabetes are also less likely
to participate in regular physical activity and therefore at a higher risk of developing chronic
musculoskeletal conditions, such as back and neck pain [15].
Although, in theory, there are strong links between the two conditions, the nature and mag-
nitude of the association between spinal pain and diabetes is still unclear. The aim of this
review, therefore, is to identify and appraise the literature on the association between diabetes
and back, neck or spinal pain. The findings will have a substantial impact on the management
and prevention of these two highly burdensome conditions.
Methods
Data sources and searches
This systematic review was conducted in accordance with the PRISMA guidelines [16] and
was prospectively registered on PROSPERO (protocol number CRD42016050738) (S1 Text).
A systematic electronic search was performed using the following databases, including auto-
mated updates, from inception to October 2017: MEDLINE, EMBASE, CINAHL, and Web of
Diabetes and neck and back pain
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Science. To identify potential studies, we used keywords related to the exposure (e.g. diabetes,
insulin resistance), outcome (e.g. back pain, neck pain) and study design (e.g. cohort study,
incidence) (S1 Table). The first screening of potentially relevant records was conducted by one
author (DP) based on titles and abstract, and two authors (DP and LA) independently per-
formed the final selection of included trials based on full-text evaluation. A third reviewer arbi-
trated in cases of disagreement (MLF). The reference lists of included papers were also
checked to ensure that all eligible studies were identified.
Study selection
Cross-sectional, case-control, twin-control and cohort observational studies that evaluated the
associations between type 1 or type 2 diabetes and non-specific back, neck or spinal pain were
included. To be eligible, studies had to be full reports and include participants older than 18
years of age with the conditions of interest (diabetes and non-specific back pain, neck pain or
both).
Studies were excluded from this review if they: i) included sites of pain other than back or
neck and did not present separate results for the symptom of interest; ii) included patients
with severe spine pathology (e.g., cancer, fracture, infectious bone disease); iii) included data
on multiple diseases and did not present separate results for association between diabetes,
back or neck pain; or iv) were not written in English. Randomised controlled trials, single-case
studies and animal studies were also excluded, as were those focusing on gestational diabetes,
pre-diabetes and any other type of non-type 1 or 2 diabetes.
Data extraction
A standardized data extraction form was used by two independent reviewers (DP and LA) to
gather data from the included studies on study design, sample characteristics, back and neck
pain, diabetes and associations of interest. A third author (MLF) resolved disagreements in
data extraction. Authors from published studies were contacted to request additional informa-
tion or data that were not reported in the original articles.
Methodological quality assessment
The methodological quality of included studies was assessed by two independent reviewers
(DP and GV) using the Newcastle-Ottawa Scale (NOS)[17] as recommended by the Cochrane
Collaboration [18]. The NOS for assessing cohort studies consists of eight items grouped into
three categories, namely: selection, comparability, and outcome. A star system, ranging from
zero to eight stars, is used to classify the quality of the study being reviewed (the more stars the
study receives in each category, the higher its methodological quality). Based on previous stud-
ies [19], an adapted version of the original scale was used to assess cross-sectional studies.
After the independent assessment of included studies by reviewers, each study received the fol-
lowing categorical score representing its quality: good (3 or 4 stars in selection domain AND 1
or 2 stars in comparability domain AND 2 or 3 stars in outcome domain), fair (2 stars in selec-
tion domain AND 1 or 2 stars in comparability domain AND 2 or 3 stars in outcome domain)
or poor (0 or 1 star in selection domain OR 0 stars in comparability domain OR 0 or 1 star in
outcome domain).
Data analysis
Meta-analyses were performed to assess the associations between predictor groups (i.e. partici-
pants with diabetes and participants without diabetes) and outcomes of interest (i.e. back or
Diabetes and neck and back pain
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neck pain), using a random effects model. Similar studies were grouped according to site of
pain [i.e. low back, neck or spinal pain (concurrent low back and neck pain)] and study design
(cross-sectional or longitudinal). The pooled associations are expressed as the odds ratios
(with 95% confidence intervals) for back, neck, or spinal pain separately, and presented by
study design (i.e. cross-sectional or longitudinal). Between-study heterogeneity was calculated
using I2 (I2 <25%: small heterogeneity; 25%<I2< 75%: moderate heterogeneity; I2> 75%:
large heterogeneity). All meta-analyses were conducted using Comprehensive Meta-Analysis
software (Comprehensive Meta-Analysis, Englewood, New Jersey, US).
Funnel plots were built for each meta-analysis to assess possible publication bias. We plot-
ted the precision (i.e. standard error) of included studies against the estimates of association
and results were visually inspected. Egger’s test was used to quantify plot asymmetry, for
which a null hypothesis represents symmetry of the plotted data.
Results
The search identified a total of 27,779 studies. After removing duplicates and screening titles,
462 abstracts were assessed for inclusion. A total of 451 abstracts were excluded, leaving 11
studies to be included in the review [20–30] (Fig 1).
Included studies
Eleven studies [20–30] that included 165,445 participants assessed the association between dia-
betes and neck, back or spinal pain. Studies reported data from six different countries: Canada
[29], Finland [26], Iran [21], Spain [20], Denmark [22, 23, 27] and the United States [24, 25,
28, 30]. Sample characteristics, study design and estimates for the associations of each study
are presented in Table 1. The authors defined neck and back pain as having pain, aching or
stiffness in the neck or back on most days. Participants were considered to have diabetes if
they reported the condition during the first interview either with or without a health profes-
sional diagnosis. Two studies included only participants with type 2 diabetes [20, 27], however,
the remainder of the included studies did not report the type of diabetes, and none of the
included studies presented disaggregated results for type 1 and type 2 diabetes. All studies pre-
sented results from cross-sectional analyses investigating the association between diabetes and
a range of outcomes related to back or neck pain, including lifetime prevalence [20–30], pain
severity [20, 27] and hospital admissions related to back pain [28]. One study also presented
longitudinal data on the association between diabetes and neck, back and spinal pain [20].
Methodological quality
Six studies (55%) were rated as having good methodological quality (i.e. score of 6 or more)
[20, 22, 23, 25, 28, 29], three studies (27%) were rated as fair (i.e. score 5) [24, 26, 30] and the
remaining two studies (18%) [21, 27] were rated as poor (score of 2). All studies had satisfac-
tory sample sizes, nine studies (82%, [20, 22–26, 28–30]) conducted adjustments for potential
confounders (e.g. age or sex); eight studies (73%, [20, 22–24, 26, 28–30]) clearly described the
statistical analyses utilized and five studies (45%, [20, 22, 23, 25, 28]) conducted retrospective
analyses of secure records (S1 Fig).
Assessment of publication bias
No evidence of small study bias was observed for the studies included in our pooled analyses
of low back and neck pain. The evidence was confirmed through visual inspection of funnel
plots and the results of Egger’s test (β 2.03; 95% CI -5.16 to 9.23, p = 0.51; S2 Fig). Due to the
Diabetes and neck and back pain
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low number of studies in the severe neck pain and spinal pain meta-analysis (<4), it was not
possible to conduct funnel plots to ascertain publication bias.
Association between diabetes and low back pain
Seven cross-sectional studies [20, 22, 24, 25, 27–29] investigated the association between diabe-
tes and low back pain and five of these [20, 22, 24, 25, 29] presented enough data to be pooled.
Our pooled analysis showed that diabetes was significantly associated with low back pain
(n = 131,431; OR 1.35; 95% CI 1.20 to 1.52, p<0.001; I2 = 47%) (Fig 2). Data from two other
studies [21, 27] that recruited participants with low back pain who sought health care for dia-
betes were also pooled, and the association between diabetes and low back pain was found to
be statistically significant (n = 4,191; OR 2.72; 95% CI 1.55 to 4.78, p<0.001; I2 = 82%)(Fig 2).
One study [20] investigated the association between diabetes and severe low back pain and
found a significant association with adjusted analysis (n = 1,525; OR 1.63; 95% CI 1.0 to 2.64).
Only one longitudinal study [20] investigated whether diabetes at baseline increased the risk of
future chronic or severe low back pain after two years; and no significant association was evi-
dent (n = 1,077; OR 0.84; 95% CI 0.51 to 1.40 and n = 218; OR 1.91; 95% CI 0.67 to 5.46,
respectively).
Fig 1. Screening flowchart. Flowchart of search strategy and screening process.
https://doi.org/10.1371/journal.pone.0212030.g001
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Table 1. Included studies.
Author,
year
Study sample Design Assessment of
Diabetes
Assessment of Spinal
Pain
Results Quality
Score
Dario, 2017 N = 2,096 Cross-sectional
and longitudinal
twin design
Self reported Care seeking for
chronic lower back or
neck pain
After adjusting for age, sex, work-related
physical activity, BMI and smoking, diabetes
was associated with neck pain (OR 1.37; 95%
CI 1.01 to 1.85, n = 2,074) and severe neck
pain (OR 2.28; 95% CI 1.24 to 4.21, n = 1,511)
in cross-sectional analyses. No association was
observed in longitudinal analyses of mild (OR
1.16; 95% CI 0.65 to 1.91, n = 1,111) or severe
neck pain (OR 1.91; 95% CI 0.52 to 6.95,
n = 138).
Good
Mean Age = 53.6 ± 7.3
years, with type 2
diabetes.
Diabetes was not associated with mild or severe
low back pain in cross-sectional (OR 1.18; 95%
CI 0.86 to 1.60; n = 2,084 and OR 1.63; 95% CI
1.0 to 2.64; n = 1,525, respectively) or
longitudinal analyses (OR 0.84; 95% CI 0.51 to
1.40; n = 1,077 for mild and OR 1.91; 95% CI
0.67 to 5.46; n = 218 for severe low back pain).
Duration of diabetes:
not reported.
Diabetes did not increase the risk of developing
spinal pain or severe spinal pain after 2 to 4
years (n = 1,284, OR 0.85, 95% CI 0.42 to 1.73
and n = 98; OR 3.67, 95% CI 0.84 to 16.03,
respectively).
Eivazi, 2012 N = 417 Cross-sectional Self reported Self-reported low back
pain in the last 12
months
The group with diabetes had a higher
incidence of low back pain than the group
without diabetes (63.4% and 47%, respectively,
p = 0.009).
Poor
Mean Age = 52.5 years
old, with diabetes.
Duration of diabetes:
not reported.
Hartvigsen,
2003
N = 4,484 Cross-sectional
twin design
Self reported Self-reported back pain
in the last month
After adjusting for sex and age, diabetes was not
associated with back pain (OR 1.15; 95% CI
0.94–1.42).
Fair
Mean age = 81 years old.
Duration of diabetes:
not reported.
Hartvigsen,
2004
N = 4,486 Cross-sectional
twin design
Self reported Prevalence of back or
neck pain in the last
month
After adjusting for age, sex and non-
independence of twins, diabetes was not
associated with back pain (OR 1.15; 95% CI
0.94–1.42) or neck pain (OR 1.19; 95% CI 0.98–
1.47).
Fair
Age range: 70 to 102
years old.
Duration of diabetes not
reported.
Hassoon,
2017
N = 5,106 Cross-sectional Self reported Chronic low back pain After adjusting for age, sex, race, education,
income, smoking, physical activity and BMI,
diabetes was associated with chronic low back
pain (OR 1.38; 95% CI 1.02–1.92, p = 0.041).
Good
Age = 43 ± 13.7 years
old, with diabetes.
Duration of diabetes not
reported.
Hinyard,
2016
N = 3,645 Cross-sectional Self reported Chronic low back pain After adjusting for age, sex, race and
comorbidities, a higher proportion of the
group with diabetes had chronic low back pain
than the group without diabetes (25.3% and
16.5%, p<0.0001, respectively).
Good
Age = 59.8 ± 14 years
old, with diabetes.
Duration of diabetes not
reported.
Ma¨kela,
1991
N = 7,217 Cross-sectional Self reported Chronic neck syndrome After adjusting for age and sex, diabetes was not
associated with chronic neck pain (OR 1.04;
95% CI 0.78–1.39).
Fair
Age:� 30 years old,
with neck pain for over
3 months.
Duration of diabetes not
reported.
(Continued)
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One study [28] assessed the association between diabetes and back pain and found diabetes
increased the likelihood of an inpatient admission in the two years subsequent to the index
back pain event by 102% (95% CI 1.69 to 2.40).
Association between diabetes and neck pain
Four cross-sectional studies [20, 23, 26, 30] investigated the association between diabetes and
neck pain, and two of these [20, 23] presented enough data to be pooled. Our pooled analyses
showed that diabetes was associated with neck pain (n = 6,560; OR 1.24; 95% CI 1.05 to 1.47;
p = 0.01; I2 = 0%) (Fig 2). One study [20] investigated the association between diabetes and
severe neck pain and found a significant association in both unadjusted (n = 1,515; OR 2.11;
95% CI 1.17 to 3.79) and adjusted (n = 1,515; OR 2.28; 95% CI 1.24 to 4.21) analyses. The same
paper [20] reported data from longitudinal analysis and showed that diabetes was not associ-
ated with increased risk of developing neck pain (n = 1,111; OR 1.16; 95% CI 0.65 to 1.91) or
severe neck pain (n = 138; OR 1.91; 95% CI 0.52 to 6.95) after two years follow-up.
One study [26] assessed the association between chronic neck syndrome and diabetes in
adults and the association was not found to be statistically significant (n = 412; OR 1.04; 95%
CI 0.78 to 1.39). One study [30] assessed the association between diabetes and mild or moder-
ate/severe neck pain and no association was found (n = 154; OR 1.3; 95% CI 0.9 to 1.9 and
n = 187; OR 0.8; 95% CI 0.6 to 1.3, respectively).
Association between diabetes and spinal pain
Two cross-sectional studies [20, 23] investigated the association between diabetes and spinal
pain (low back and neck pain). Pooling of data from these studies showed diabetes was associ-
ated with spinal pain (n = 6,570; OR 1.37; 95% CI 1.07 to 1.75; p = 0.01; I2 = 25%) (Fig 2). One
longitudinal study [20] found no association between diabetes and increased risk of developing
Table 1. (Continued)
Author,
year
Study sample Design Assessment of
Diabetes
Assessment of Spinal
Pain
Results Quality
Score
Molsted,
2012
N = 3,874 Cross-sectional Self reported Self-reported
prevalence of neck or
low back pain in the last
14 days
Musculoskeletal pain was consistently more
prevalent in participants with diabetes when
compared to the general population.
Poor
Age = 60 ± 10 years old,
with type 2 diabetes
Duration of diabetes
4 ± 4.3 years.
Ritzwoller,
2006
N = 16,567 Cross-sectional Medically
diagnosed
Hospital admission
after a low back pain
event
After adjusting for age and sex, diabetes was
associated with a higher risk of hospital
admission after a low back pain event (OR
2.02; 95% CI 1.69–2.40).
Good
Age = 51.1 years old,
with low back pain.
Duration of diabetes not
reported.
Slater, 2011 115,915 Cross-sectional Self reported Low back pain for the
last 6 months
After adjusting for age, sex, income, education,
race, BMI and multimorbidity, diabetes was
associated with back problems (OR 1.36; 95%
CI 1.28–1.45).
Good
Age:� 20 years old.
Duration of diabetes not
reported.
Wright,
2016
N = 1,638 Cross-sectional Self reported Neck pain After adjusting for age, sex, BMI and race,
diabetes was associated with mild neck pain
(OR 1.6; 95% CI 1.1–2.3) but not moderate/
severe neck pain (OR 1.0; 95% CI 0.7–1.5).
Good
Age = 68 years old, with
neck pain.
Duration of diabetes not
reported.
Characteristics of included studies. Bold denotes significance at the 0.05 level.
https://doi.org/10.1371/journal.pone.0212030.t001
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spinal pain or severe spinal pain (n = 1,284, OR 0.85, 95% CI 0.42 to 1.73 and n = 98; OR 3.67,
95% CI 0.84 to 16.03, respectively).
Discussion
Main findings
This review aimed to appraise and summarize the literature regarding the association between
diabetes and low back, neck or spinal (both low back and neck) pain. We found eleven studies
that investigated the association between diabetes and a range of outcomes related to back,
neck and spinal pain.
Our pooled cross-sectional results suggest that people with diabetes are significantly more
likely to report back, neck, and spinal pain than those without diabetes; with odds ratios rang-
ing from 1.24 to 2.72. The association with diabetes and back pain was stronger among people
seeking care for diabetes (OR 2.72; 95% CI 1.55 to 4.78) (Fig 2). This change could be due to
participants having higher average BMI, more severe diabetes (i.e. higher glycated haemoglo-
bin, indicative of poorer glycaemic control) and/or diabetes for a longer duration. If patients
seeking care were those with poorer metabolic control, it might indicate that they were more
prone to developing more prevalent and more severe associated complications, including back
pain.
Our review only identified one longitudinal study assessing the association between diabe-
tes and the development of future neck, low back or spinal pain. The study did not find any
evidence of a temporal effect. Together, the findings of our review suggest that there is a posi-
tive association between diabetes and neck, low back and spinal pain. However, the currently
limited evidence does not support a causal relationship between diabetes and back pain due to
a lack of evidence of any temporal effect. Furthermore, the only included study that reported
longitudinal analyses had a reduced sample size for the longitudinal analysis and used a fol-
low-up duration of only two to four years, which may be considered short and insufficient to
show an effect of time on the association between diabetes and spinal pain.
Fig 2. Meta-analysis of included studies. Pooled odds ratios and confidence intervals for the associations between diabetes and back, neck
and spinal pain in cross-sectional studies.
https://doi.org/10.1371/journal.pone.0212030.g002
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If diabetes is not a true risk factor for back pain, another possible factor explaining the
cross-sectional association may be the underlying presence of obesity. At the age of 18, men
with higher BMI (i.e. BMI>35) are over nine times more likely to develop diabetes when com-
pared to underweight men (i.e. BMI<18.5) [13]. People with higher BMI are also 30% more
likely to develop chronic low back pain over a period of 10 years [31]. Obesity is likely to pre-
dispose people to develop the two conditions via different pathways, including metabolic [e.g.
low-grade systemic inflammation [11, 32] and/or dyslipidaemia [33]] and biomechanical
(joint loading) [34, 35] mechanisms. However, four of the eleven included studies [20, 24, 29,
30] adjusted their cross-sectional analyses for BMI, of which two [29, 30] found a significant
association between low back pain and diabetes, independent of BMI. While BMI may not
accurately reflect obesity status in some participants, the significant association suggests that
despite the critical role of obesity, it does not fully explain the relationship between diabetes
and back pain, requiring other potential confounders to be accounted for.
Some other possible explanations for a cross-sectional relationship between diabetes, neck,
low back and spinal pain are also plausible. For example, the biochemical milieu of diabetes,
including hyperglycaemia and dyslipidaemia facilitates tissue damage, mainly due to detri-
mental effects on blood vessels, and it is plausible that its presence may, therefore, be directly
linked to pain [36]. Poorly controlled diabetes can also reduce muscle blood flow [37], increase
the likelihood of cartilage inflammation [38] and other tissue damage, such as degeneration of
intervertebral discs [39] and consequently spinal canal stenosis [40], which are both common
causes of low back and neck pain [21]. Previous research reports that participants with diabetes
are more likely to be treated for intervertebral disc herniation of both the cervical [41] and
lumbar spine [42]. Diabetes is also known to be associated with loss of muscle mass and
strength [43] and is associated with an increased risk of sarcopenia, which is also associated
with musculoskeletal pain [44]. Despite these associations and our results having shown a
direct link between low back, neck or spinal pain and diabetes, there is insufficient evidence to
support the notion that diabetes will increase the risk of future low back, neck or spinal pain.
Finally, it is also possible that a low level of physical activity participation is an underlying
factor predisposing people to both conditions. Regular physical activity participation is known
to decrease the risk of both low back pain [9] and type 2 diabetes [10], especially when com-
bined with diet [45].
Strengths and limitations of the study
One of the main strengths of this study is the broad search strategy aimed to maximize the
identification of possible references to be screened and included. Our review included studies
from six countries representing three global regions, increasing the generalizability of our
results. However, a limitation of our study is the inability to conduct separate analyses for type
1 and type 2 diabetes, since none of the included studies reported disaggregated data. There
was a broad diversity of outcomes investigated in the included studies, and due to these differ-
ences with respect to design, basic characteristics of the populations and outcomes assessed,
we chose to pool studies according to the pain site (i.e. back or neck pain). Thus our final site-
specific results may underestimate the real association between diabetes and back or neck
pain.
Some between-study heterogeneity was observed in the pooled analysis of low back pain
studies that included participants who sought care for diabetes. The variability between
included studies may possibly be explained by study design (e.g. different length of recruit-
ment periods), definitions of low back pain (i.e. self-reported low back pain with or without
leg pain or exclusively low back pain) or type of diabetes (e.g. type 2 only or type not
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disclosed). Moreover, only one of the included studies adjusted their analyses for age and gen-
der, which may also have contributed for the between-trial heterogeneity.
Directions for future research
The use of medication to better control diabetes was reported by only one included study [25]
with the group who used insulin presenting a higher prevalence of chronic conditions, includ-
ing low back pain. The use of diabetes medication could influence pain, possibly via its effect
on glycaemic control (i.e. glycated haemoglobin and glucose levels), which influences macro-
and microvascular complications [46] and via the medication’s analgesic properties [47]. Insu-
lin is also known to affect blood flow [48] which can influence muscle loss [49]. The impact of
these medications should be further explored in future studies. Given that we could only iden-
tify one longitudinal study assessing the association between diabetes and low back or neck
pain, future studies should be conducted to confirm these results in larger samples that are rep-
resentative of the general population. Future longitudinal studies addressing the association
between diabetes and low back or neck pain should include the duration of diabetes and pain
symptoms. This will provide important information on the nature of the association between
the two conditions.
Conclusion
This review highlights a positive association between diabetes and low back or spinal pain.
However, given the lack of evidence from longitudinal studies, it is unknown whether the asso-
ciation is causal. Future studies should aim to elucidate the mechanisms of the association to
provide an opportunity to target preventive and management strategies for people with
diabetes.
Supporting information
S1 Checklist. Preferred reporting items for systematic reviews and meta-analyses—
PRISMA 2009 checklist.
(DOC)
S1 Text. PROSPERO review protocol.
(PDF)
S1 Table. A systematic search was conducted in the MEDLINE, CINAHL, EMBASE and
Web of Science electronic databases. Articles titles, keywords and abstracts were searched
using the following keywords:
(DOCX)
S1 Fig. Methodological quality assessment of included studies.
(DOCX)
S2 Fig. Funnel plot used to assess the presence of publication bias through visual inspec-
tion.
(DOCX)
Author Contributions
Conceptualization: Daniel Pozzobon, Paulo H. Ferreira, Manuela L. Ferreira.
Data curation: Daniel Pozzobon, Amabile B. Dario, Lisandra Almeida, Giovana Vesentini,
Manuela L. Ferreira.
Diabetes and neck and back pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0212030 February 21, 2019 10 / 13
85
Formal analysis: Daniel Pozzobon, Paulo H. Ferreira, Amabile B. Dario, Lisandra Almeida,
Giovana Vesentini, Alison R. Harmer, Manuela L. Ferreira.
Investigation: Daniel Pozzobon, Paulo H. Ferreira, Amabile B. Dario, Lisandra Almeida, Gio-
vana Vesentini, Alison R. Harmer, Manuela L. Ferreira.
Methodology: Daniel Pozzobon, Paulo H. Ferreira, Amabile B. Dario, Alison R. Harmer,
Manuela L. Ferreira.
Project administration: Daniel Pozzobon, Paulo H. Ferreira, Manuela L. Ferreira.
Supervision: Paulo H. Ferreira, Amabile B. Dario, Alison R. Harmer, Manuela L. Ferreira.
Validation: Paulo H. Ferreira, Amabile B. Dario, Lisandra Almeida, Giovana Vesentini, Alison
R. Harmer, Manuela L. Ferreira.
Writing – original draft: Daniel Pozzobon, Paulo H. Ferreira, Amabile B. Dario, Lisandra
Almeida, Giovana Vesentini, Alison R. Harmer, Manuela L. Ferreira.
Writing – review & editing: Daniel Pozzobon, Paulo H. Ferreira, Amabile B. Dario, Lisandra
Almeida, Giovana Vesentini, Alison R. Harmer, Manuela L. Ferreira.
References
1. Walker BF, Muller R, Grant WD. Low back pain in Australian adults: prevalence and associated disabil-
ity. J Manipulative Physiol Ther. 2004; 27(4):238–44. https://doi.org/10.1016/j.jmpt.2004.02.002 PMID:
15148462
2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabe-
tes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice. 2014; 103
(2):137–49. https://doi.org/10.1016/j.diabres.2013.11.002 PMID: 24630390
3. Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic
peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29(7):1518–22 5p. https://doi.org/10.
2337/dc05-2228 PMID: 16801572
4. Pai L-W, Hung C-T, Li S-F, Chen L-L, Chung Y-C, Liu H-L. Musculoskeletal pain in people with and with-
out type 2 diabetes in Taiwan: a population-based, retrospective cohort study. BMC Musculoskeletal
Disorders. 2015; 16(1):364.
5. Krein SL, Heisler M, Piette JD, Makki F, Kerr EA. The effect of chronic pain on diabetes patients’ self-
management. Diabetes Care. 2005; 28(1):65–70 6p. PMID: 15616235
6. Sakellaridis N. The influence of diabetes mellitus on lumbar intervertebral disk herniation. Surg Neurol.
2006; 66(2):152–4. https://doi.org/10.1016/j.surneu.2006.01.019 PMID: 16876608
7. Fields AJ, Berg-Johansen B, Metz LN, Miller S, La B, Liebenberg EC, et al. Alterations in intervertebral
disc composition, matrix homeostasis and biomechanical behavior in the UCD-T2DM rat model of type
2 diabetes. Journal of Orthopaedic Research. 2015; 33(5):738–46. https://doi.org/10.1002/jor.22807
PMID: 25641259
8. Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with over-
weight and obesity in Ireland: the effects of a small BMI reduction at population level. BMC Public
Health. 2014; 14(1):143.
9. Searle A, Spink M, Ho A, Chuter V. Exercise interventions for the treatment of chronic low back pain: a
systematic review and meta-analysis of randomised controlled trials. Clinical Rehabilitation. 2015; 29
(12):1155–67. https://doi.org/10.1177/0269215515570379 PMID: 25681408
10. Aune D, Norat T, Leitzmann M, Tonstad S, Vatten LJ. Physical activity and the risk of type 2 diabetes: a
systematic review and dose–response meta-analysis. European Journal of Epidemiology. 2015; 30
(7):529–42. https://doi.org/10.1007/s10654-015-0056-z PMID: 26092138
11. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, et al. Sarcopenia,
obesity, and inflammation—results from the Trial of Angiotensin Converting Enzyme Inhibition and
Novel Cardiovascular Risk Factors study. The American journal of clinical nutrition. 2005; 82(2):428–
34. https://doi.org/10.1093/ajcn.82.2.428 PMID: 16087989
Diabetes and neck and back pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0212030 February 21, 2019 11 / 13
86
12. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al. Low-Grade Systemic
Inflammation and the Development of Type 2 Diabetes. The Atherosclerosis Risk in Communities
Study. 2003; 52(7):1799–805.
13. Narayan KMV, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on Lifetime Risk for
Diabetes in the U.S. Diabetes Care. 2007; 30(6):1562. https://doi.org/10.2337/dc06-2544 PMID:
17372155
14. Webb R, Brammah T, Lunt M, Urwin M, Allison T, Symmons D. Prevalence and predictors of intense,
chronic, and disabling neck and back pain in the UK general population. Spine (Phila Pa 1976). 2003;
28(11):1195–202.
15. Qiu S-h, Sun Z-l, Cai X, Liu L, Yang B. Improving Patients’ Adherence to Physical Activity in Diabetes
Mellitus: A Review. Diabetes & Metabolism Journal. 2012; 36(1):1–5.
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement
for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions:
explanation and elaboration. The BMJ. 2009; 339:b2700. https://doi.org/10.1136/bmj.b2700 PMID:
19622552
17. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale
(NOS) for assessing the quality of nonrandomised studies in meta-analyses. [cited 2017 29/08/17].
Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
18. Higgins J, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version
5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from: http://handbook.
cochrane.org.
19. Herzog R, A´ lvarez-Pasquin MJ, Dı´az C, Del Barrio JL, Estrada JM, Gil A´ . Are healthcare workers’ inten-
tions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review. BMC Public
Health. 2013; 13(1):154.
20. Dario A, Ferreira M, Refshauge K, Harmer A, Sanchez-Romera J, Perez-Riquelme F, et al. Mapping
the association between back pain and type 2 diabetes: A cross-sectional and longitudinal study of
adult Spanish twins. PloS one. 2017; 12(4):e0174757–e. https://doi.org/10.1371/journal.pone.0174757
PMID: 28369107
21. Eivazi M, Abadi L. Low Back Pain in Diabetes Mellitus and Importance of Preventive Approach. Health
Promotion Perspectives. 2012; 2(1):80–8. https://doi.org/10.5681/hpp.2012.010 PMID: 24688921
22. Hartvigsen J, Christensen K, Frederiksen H. Back pain remains a common symptom in old age. a popu-
lation-based study of 4486 Danish twins aged 70–102. Eur Spine J. 2003; 12(5):528–34. https://doi.org/
10.1007/s00586-003-0542-y PMID: 12748896
23. Hartvigsen J, Christensen K, Frederiksen H. Back and neck pain exhibit many common features in old
age: a population-based study of 4,486 Danish twins 70–102 years of age. Spine (03622436). 2004; 29
(5):576–80 5p.
24. Hassoon A, Bydon M, Kerezoudis P, Maloney PR, Rinaldo L, Yeh H-C. Chronic low-back pain in adult
with diabetes: NHANES 2009–2010. Journal of Diabetes and its Complications. 2017; 31(1):38–42.
https://doi.org/10.1016/j.jdiacomp.2016.10.025 PMID: 27838098
25. Hinyard LJ, Geremakis CM. Assessing health related quality of life in persons with diabetes: A compari-
son of generic measures. Open Public Health Journal. 2016; 9:65–74.
26. Ma¨kela M, Helio¨vaara M, Sievers K, Impivaara O, Knekt P, Aromaa A. Prevalence, Determinants, and
Consequences of Chronic Neck Pain in Finland. Am J Epidemiol. 1991; 134(11):1356–67. PMID:
1755449
27. Molsted S, Tribler J, Snorgaard O. Musculoskeletal pain in patients with type 2 diabetes. Diabetes
Research and Clinical Practice. 2012; 96(2):135–40. https://doi.org/10.1016/j.diabres.2011.12.022
PMID: 22244365
28. Ritzwoller DP, Crounse L, Shetterly S, Rublee D. The association of comorbidities, utilization and costs
for patients identified with low back pain. BMC Musculoskeletal Disorders. 2006; 7:72. https://doi.org/
10.1186/1471-2474-7-72 PMID: 16982001
29. Slater M, Perruccio AV, Badley EM. Musculoskeletal comorbidities in cardiovascular disease, diabetes
and respiratory disease: the impact on activity limitations; a representative population-based study.
BMC Public Health. 2011; 11(1):77.
30. Wright AR, Shi XYA, Busby-Whitehead J, Jordan JM, Nelson AE. The Prevalence of Neck and Shoul-
der Symptoms and Associations with Comorbidities and Disability: The Johnston County Osteoarthritis
Project. J Musculoskelet Pain. 2015; 23(1–2):34–44.
31. Heuch I, Heuch I, Hagen K, Zwart J-A. Body mass index as a risk factor for developing chronic low back
pain: a follow-up in the Nord-Trøndelag Health Study. Spine. 2013; 38(2):133–9. https://doi.org/10.
1097/BRS.0b013e3182647af2 PMID: 22718225
Diabetes and neck and back pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0212030 February 21, 2019 12 / 13
87
32. Kaur J. A comprehensive review on metabolic syndrome. Cardiology research and practice. 2014;
2014:943162. https://doi.org/10.1155/2014/943162 PMID: 24711954
33. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.
World Journal of Diabetes. 2015; 6(3):456–80. https://doi.org/10.4239/wjd.v6.i3.456 PMID: 25897356
34. Messier SP, Gutekunst DJ, Davis C, DeVita P. Weight loss reduces knee-joint loads in overweight and
obese older adults with knee osteoarthritis. Arthritis Rheum. 2005; 52(7):2026–32. https://doi.org/10.
1002/art.21139 PMID: 15986358
35. Vincent HK, Raiser SN, Vincent KR. The aging musculoskeletal system and obesity-related consider-
ations with exercise. Ageing Research Reviews. 2012; 11(3):361–73. https://doi.org/10.1016/j.arr.
2012.03.002 PMID: 22440321
36. Yamagishi S-i. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vas-
cular damage in diabetes. Experimental Gerontology. 2011; 46(4):217–24. https://doi.org/10.1016/j.
exger.2010.11.007 PMID: 21111800
37. Groen BBL, Hamer HM, Snijders T, van Kranenburg J, Frijns D, Vink H, et al. Skeletal muscle capillary
density and microvascular function are compromised with aging and type 2 diabetes. Journal of Applied
Physiology. 2014; 116(8):998–1005. https://doi.org/10.1152/japplphysiol.00919.2013 PMID: 24577061
38. Laiguillon MC, Courties A, Houard X, Auclair M, Sautet A, Capeau J, et al. Characterization of diabetic
osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward patho-
physiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthritis and Cartilage. 2015;
23(9):1513–22. https://doi.org/10.1016/j.joca.2015.04.026 PMID: 25987541
39. Teraguchi M, Yoshimura N, Hashizume H, Muraki S, Yamada H, Oka H, et al. Metabolic Syndrome
Components Are Associated with Intervertebral Disc Degeneration: The Wakayama Spine Study. Plos
One. 2016; 11(2).
40. Asadian L, Haddadi K, Aarabi M, Zare A. Diabetes Mellitus, a New Risk Factor for Lumbar Spinal Steno-
sis: A Case–Control Study. Clinical Medicine Insights Endocrinology and Diabetes. 2016; 9:1–5. https://
doi.org/10.4137/CMED.S39035 PMID: 27168730
41. Sakellaridis N, Androulis A. Influence of diabetes mellitus on cervical intervertebral disc herniation. Clini-
cal Neurology and Neurosurgery. 2008; 110(8):810–2. https://doi.org/10.1016/j.clineuro.2008.05.007
PMID: 18573593
42. Sakellaridis N. The influence of diabetes mellitus on lumbar intervertebral disk herniation. Surgical Neu-
rology. 2006; 66(2):152–4. https://doi.org/10.1016/j.surneu.2006.01.019 PMID: 16876608
43. Almurdhi MM, Reeves ND, Bowling FL, Boulton AJM, Jeziorska M, Malik RA. Reduced Lower-Limb
Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular
Fat, and Vitamin D Levels. Diabetes Care. 2016; 39(3):441–7. https://doi.org/10.2337/dc15-0995
PMID: 26740641
44. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and Determinant Factors of
Sarcopenia in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes
Care. 2010; 33(7):1497–9. https://doi.org/10.2337/dc09-2310 PMID: 20413515
45. Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined diet and physical
activity promotion programs to prevent type 2 diabetes among persons at increased risk: A systematic
review for the community preventive services task force. Annals of Internal Medicine. 2015; 163
(6):437–51. https://doi.org/10.7326/M15-0452 PMID: 26167912
46. Fabiane SM, Ward KJ, Iatridis JC, Williams FMK. Does type 2 diabetes mellitus promote intervertebral
disc degeneration? European Spine Journal. 2016; 25(9):2716–20. https://doi.org/10.1007/s00586-
016-4612-3 PMID: 27272275
47. Martini C, Yassen A, Olofsen E, Passier P, Stoker M, Dahan A. Pharmacodynamic analysis of the anal-
gesic effect of capsaicin 8% patch (Qutenza) in diabetic neuropathic pain patients: detection of distinct
response groups. Journal of Pain Research. 2012; 5:51–9. https://doi.org/10.2147/JPR.S30406 PMID:
22536092
48. Clark MG, Wallis MG, Barrett EJ, Vincent MA, Richards SM, Clerk LH, et al. Blood flow and muscle
metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab. 2003; 284(2):E241–58. https://
doi.org/10.1152/ajpendo.00408.2002 PMID: 12531739
49. Welch AA. Nutritional influences on age-related skeletal muscle loss. Proc Nutr Soc. 2013; 73(1):16–
33. https://doi.org/10.1017/S0029665113003698 PMID: 24229650
Diabetes and neck and back pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0212030 February 21, 2019 13 / 13
88
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  4 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, 
outcomes, and study design (PICOS).  
5 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
5 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
6 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
5 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated. 
Appendix 1 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
6 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
7 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
7 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
7 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).   
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I
2
) for each meta-analysis.  
8 
 
Page 1 of 2  
89
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
8 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating 
which were pre-specified.  
 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at 
each stage, ideally with a flow diagram.  
9 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and 
provide the citations.  
10-14 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  15 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
17 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  15-17 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  15 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).   
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
17 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
20 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  20 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the 
systematic review.  
22 
 
From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. 
doi:10.1371/journal.pmed1000097  
For more information, visit: www.prisma-statement.org.  
Page 2 of 2  
90
Supplementary File 1 Table 
A systematic search was conducted in the MEDLINE, CINAHL, EMBASE and Web of Science 
electronic databases. Articles titles, keywords and abstracts were searched using the 
following keywords: 
Diabetes Neck Back Pain Systematic Review 
Alloxan Diabetes atlant* Back Injuries cohort studies 
Streptozocin Diabetes  atlanto-accipital joint Back Muscles  course 
Streptozotocin Diabetes atlato-axial joint backache cox 
Adult-Onset Diabetes Mellitus axis coccydynia cox adj3 regre* 
Autoimmune Diabetes brachialgia coccyx follow-up studies 
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Funnel plot used to assess the presence of publication bias through visual inspection. 
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Abstract
Background
Regular physical activity participation is known to promote better mobility and coordination.
Although previous research has established that lack of physical activity participation may
increase the risk of developing low back pain, the role of physical activity as a predictor of
recovery among symptomatic individuals remains unclear.
Objective
To evaluate whether: (i) the level of physical activity participation before an acute episode of
low back pain predicts recovery within 12 months following the acute pain episode (i.e.
index episode); and (ii) participants return to their pre-pain level of physical activity participa-
tion 12 months from the index episode.
Design
This study used longitudinal data from the TRIGGERS case-crossover study.
Setting
This study was conducted through over-the-phone interviews to participants that presented
to 300 primary care clinics with a new episode of acute low back pain.
Participants
This study included 999 consecutive patients, aged 18 years or older. Follow-up assess-
ment was completed at 12 months following the index episode.
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Methods
This is a cohort study where consecutive patients, aged 18 years or older, that presented
with a new episode of acute low back pain were recruited between October 2011 and
November 2012.
Main outcome measurements
Self-reported level of physical activity participation.
Results
A total of 830 participants completed the study. When comparing participants who reported
pain at 12 months follow-up with those without pain, all participants reported similar levels of
physical activity participation one week before (p = 0.449), one week after (p = 0.812) and
12 months after the index episode (p = 0.233). The level of physical activity participation
before the index episode was not a reliable predictor of presence of pain at either 3 or 12
months follow-up (OR 0.99; 95% CI 0.993 to 1.003; p = 0.523 and OR 1; 95% CI 0.992 to
1.008; p = 0.923, respectively).
Conclusion
Physical activity participation did not predict recovery from the pain episode. Also all partici-
pants returned to their pre-pain level of physical activity participation after 12 months.
Introduction
Low back pain is a common condition, with a lifetime prevalence of approximately 80% [1, 2].
Given its high prevalence, the costs associated with this condition are considerable. In the
United Kingdom, the total annual health-care expenditure related to low back pain is esti-
mated at £ 11 billion, and in the United States the annual cost with treatment for low back
pain is estimated to be US$ 90 billion [3]. A recent report shows that over 3.2 million Austra-
lian reported chronic pain from either arthritis or back pain and the majority of these individ-
uals (56%) also reported activity limitations due to the pain [4]. The prevalence of chronic
pain is expected to affect over 5.2 million Australians by 2050 with over 2.9 million individuals
experiencing activity limitation due to pain [4].
Regular physical activity participation is known to promote better mobility and coordina-
tion, overall fitness, and muscle power and rapid strength [5] as well as decreasing mortality
risk [6] and cardiovascular disease risk [7]. Physical activity participation has been identified
as a potential protective factor for a number of musculoskeletal conditions, including low back
pain [8] [9], however it is still unknown if physical activity participation before an episode will
impact the course of this condition. Some domains of physical activity, such as frequency (e.g.
when too low) and intensity (e.g. when too high), are known as risk factors for the onset of low
back pain [10, 11]. This study uses data on physical activity intensity and duration to calculate
the metabolic demand and total metabolic expenditure minutes (MET min/week) of the
reported physical activities. Although previous research has established that both lack of regu-
lar physical activity participation and engagement in strenuous physical activity may increase
the risk of developing low back pain [12], the role of physical activity participation as a
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predictor of recovery among symptomatic individuals remains unclear. Moreover, it is
unknown whether individuals who recover from an episode of low back pain ever return to
their pre-pain levels of physical activity participation. This would be especially important since
the regular practice of physical activity is known to be related to better mobility, muscle power
and overall health [5, 9].
Therefore, the aim of this study was to evaluate whether: (i) the self-reported level of physi-
cal activity participation before an acute episode (index episode) of low back pain predicts
recovery within 12 months following the index pain episode; and (ii) participants return to
their pre-pain self-reported level of physical activity participation 12 months from the index
episode.
Methods
Study design
We hypothesised that participants with higher levels of physical activity (considering duration
and intensity of activity) before the index episode would be more likely to recover within the
first 12 months. We also hypothesized that those who recovered from their pain episode would
be more likely to return to their original (i.e. pre pain) levels of physical activity participation.
We used longitudinal data from the TRIGGERS for low back pain Study. The study was
approved by the Human Research Ethics Committee of the University of Sydney (protocol
number 05-2011/13742). The TRIGGERS Study was a case-crossover study designed to inves-
tigate a number of transient physical and psychosocial risk factors for an episode of sudden-
onset, acute low back pain. Follow-up assessment was completed at 3 and 12 months following
the index episode of pain, through telephone interviews. All participants were assessed by the
same team of researchers, following the same standardised assessment booklet. Detailed infor-
mation has been published elsewhere [13].
Participants
The study included 999 consecutive patients, aged 18 years or older, that presented to 300 pri-
mary care clinics (general practitioners, physical therapists, and chiropractors) with a new epi-
sode of acute low back pain (i.e. index episode). All participants gave written informed
consent for participation. Participants were referred by the clinics and recruited between Octo-
ber 2011 and November 2012 and interviewed to assess the inclusion/exclusion criteria previ-
ously described in the study protocol [14]. A new episode of acute low back pain was defined
as a primary complaint of pain between the 12th rib and the buttock crease, with or without
leg pain, causing the patient to seek health care, and preceded by a period of at least 1 month
without back pain [15]. Patients needed to present to primary care within 7 days from index
episode and report pain of at least moderate intensity in the first 24 hours (measured using
item 7 of the Short Form 36 questionnaire: “How much bodily pain have you had during the
past 4 weeks? None; Very mild; Mild; Moderate; Severe or Very severe.”) [16]. Participants
with known or suspected serious spinal pathology (metastatic, inflammatory or infective dis-
eases of the spine) were excluded.
Outcome measures
At study entry, a telephone-based interviewed was conducted within 7 days following referral
to the study. At baseline, participants were asked about their age, gender, height, weight, medi-
cation taken for the pain, employment status, type of work, manual tasks performed (e.g. lift-
ing heavy loads, awkward positioning, handling objects far from the body), a recent slit, trip or
Physical activity and acute low back pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0219556 July 10, 2019 3 / 12
98
fall, pain intensity, feelings of depression or anxiety, alcohol consumption, as well as engage-
ment in moderate or vigorous physical activity and sexual activity. The date and time of pain
onset was also identified with the assistance of recommended recall aids, such as a diary and/
or smartphone. Participants’ BMI was calculated based on the self-reported height and weight.
Participants were also asked to report pain intensity at the moment of the interview using a
numeric rating scale (0 to 6) and disability (0 to 5) based on item 7 of the SF-36 questionnaire
[17]. The SF-36 is a valid and reliable self-administered tool for measurement of physical and
social functioning [17]. The SF-36 correlation coefficient with the International Quality of Life
Assessment (IQOLA) for the physical functioning section is 0.85 and 0.42 for the social func-
tioning section, and the internal consistency reliability coefficient for the physical functioning
is 0.93 and 0.68 for social functioning.[18]. The overall internal consistency reliability of SF-36
is estimated to be 0.87 [19]. Tension or anxiety and feelings of depression were assessed based
on items 13 and 14 of the Orebro Musculoskeletal Pain Questionnaire (“How tense or anxious
have you felt in the past week?” and “How much have you been bothered by feeling depressed
in the past week?”, respectively) [20].
The self-reported level of physical activity participation was assessed using the Active Aus-
tralia Survey (AAS) questionnaire [21], where participants estimated the total number of
hours they spent engaged in light, moderate, and vigorous physical activity in the week preced-
ing the index episode, and at 1 week and at 12 months follow-up. Participants were contacted
again at 3 months and 12 months and were asked if they had recovered from the index episode,
and in case of a positive answer, the date when the pain fully resolved was used to calculate the
duration of episode. Recovery was defined as being pain-free for at least one month before the
follow-up interview [15]. This design has already been successfully used to assess physical
activity participation among persons seeking care due to low back pain [22]. Participants were
also asked at baseline and follow-up surveys about the presence and intensity of symptoms of
depression and anxiety.
Assessment of frequency and intensity of physical activity
In this study, physical activity was defined as any bodily movement that increases the meta-
bolic demand above the rest state [23]. Participants were asked about the total time spent in
physical activity of different intensities (e.g. light, moderate or vigorous) the week before pain
onset. Pain onset could have been up to 2 weeks prior to the baseline interview. The AAS ques-
tionnaire was developed focusing on the recall period of 1 week and has been shown to present
estimates of physical activity level comparable with pedometer steps and accelerometer counts
and considers physical activity of light intensity (e.g. walking briskly), moderate intensity (e.g.
gentle swimming and recreational tennis) and vigorous intensity (e.g. cycling and competitive
tennis) [24]. The AAS was developed based on the International Physical Activity Question-
naire (IPAQ) therefore we used the IPAQ-SF scoring system to calculate the metabolic
demand and total metabolic expenditure minutes (MET min/week) following the scoring sys-
tem used in the short form of the IPAQ (IPAQ-SF) for different levels of intensity of physical
activity (i.e. light = 3.3 met/min, moderate = 4 met/min and vigorous = 8 met/min) [25] for
each participant at each time point.
Statistical analysis
Patients were split into two groups according to the presence of pain at the 12-month follow-
up assessment; ‘recovered’ if they no longer reported pain and ‘not recovered’ if they reported
persistent pain. Baseline demographic variables were summarised as mean (SD) if continuous
and frequency (percent) if categorical.
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Generalised estimating equations were used to investigate the change in total metabolic
equivalent minutes over time. A time-by-group interaction term was included alongside main
effects recovery group and time-point (one-week prior to episode, week of episode and 12
months after episode) were to conduct within- and between-group comparisons at each time
point as well as across all time points.
Logistic regression models were used to assess the association between levels of physical
activity one-week prior to the pain episode and the risk of non-recovery at 12 months.
All models were adjusted for known confounders including age, gender, BMI, pain inten-
sity at index episode and depression or anxiety symptoms assessed based on Orebro Musculo-
skeletal Pain Questionnaire [8, 20].
Total Metabolic Equivalent minutes per week (MET min/week) was used to quantify physi-
cal activity participation prior to index episode and used in the analysis to predict the presence
of low back pain at the 12-month follow-up. We used the scoring system from the IPAQ-SF
since it has been validated against accelerometer data [25] and it is a well-known way to pool
physical activities of different intensities to facilitate the comparison between different activi-
ties [26]. Generalised linear models were conducted using total MET min/week as the depen-
dent variable (continuous) considering each time-point (1 week before low back pain episode,
week of the low back pain episode and 12 months after the episode) and the presence of low
back pain at 3 months and 12 months.
A sensitivity analysis was conducted, repeating the analyses on the 3-month follow-up
assessment [27]. All analyses were conducted using IBM SPSS Statistics for Windows, Version
22.0 (Armonk, NY: IBM Corp.) Statistical significance was set as p< 0.05.
Results
Of the 999 participants initially included, 83% had complete follow-up data and were included
in our study. The main reasons for not obtaining follow-up data were participants being
unavailable to respond interview (n = 139) or declining to participate (n = 28) (Fig 1). The 830
participants presented at baseline with mean low back pain duration of 4.9 (SD 3.5) days, and
mean time from pain onset to presentation to primary care of 3.0 (SD 2.1) days and 4.9 (SD
2.7) days from presentation to baseline interview. Participants’ demographic and clinical char-
acteristics are presented in Table 1. At the 12-month follow-up, 661 participants had recovered
from the initial episode of low back pain, while 169 remained symptomatic and reported hav-
ing an average of 1.7 (SD 1.2) self-reported pain intensity (0 to 6 scale) and 1.4 (SD 0.8) self-
reported disability (0 to 5 scale). Of the 661 who reported being recovered at 12 months, 597
recovered within the first 3 months post index episode.
Change in physical activity participation
For the physical activity participation analyses, participants were grouped according to their
pain status at 12 months. Both groups (i.e. participants with persistent pain and participants
who had recovered) reported similar levels of physical activity participation at all time-points
assessed: one week before the index episode (p = 0.449), one week after index episode
(p = 0.812) and 12 months after the index episode (p = 0.233) (Table 2). Participants reported
a statistically significant reduction in the mean MET minutes/week one week after the index
episode in both persistent pain (mean METs minutes/week: -788; 95% confidence interval
[CI]: -990 to -585; p<0.001) and recovered (METs minutes/week: -611; 95% CI: -723 to -498;
p<0.001) groups. At 12 months, both groups reported increases in the levels of physical activ-
ity participation similar to pre-pain levels (Fig 2). The generalised linear model confirmed a
similar pattern for physical activity participation between groups after adjusting for age,
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gender, BMI, pain intensity at event and depression, at both 3 and 12 months after the index
episode (χ2 = 3.622, p = 0.16 and χ2 = 2.963, p = 0.23, respectively).
The results of our logistic regression models showed that baseline physical activity partici-
pation (i.e., before index episode) was not a predictor of recovery at 12 months, after adjusting
for age, gender, BMI, pain intensity at baseline and depression or anxiety symptoms (AOR
Fig 1. Flowchart of participant’s recruitment and follow-up participation.
https://doi.org/10.1371/journal.pone.0219556.g001
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0.99; 95% CI 0.99 to 1.00; p = 0.523)(Table 3). Similarly, when considering those who had
recovered within the first 3 months post index episode, our sensitivity analysis showed that the
amount of physical activity before index episode did not predict recovery at 3 months (OR 1;
Table 1. Baseline characteristics of the participants presented as mean (standard deviation), unless otherwise stated.
Characteristics Mean (SD) p-value‡
Persistent pain at the 12-month follow-up (N = 169) Recovered at 12-month follow-up (N = 661)
Age, years 45.9 (13.8) 45.2 (13.4) 0.30
Gender (female/male) 76 / 94 304 / 356
Body mass index (kg/m2) 26.4 (4.5) 26.4 (5.5) 0.94
Days of episodeα 5 (2.7) 4.9 (2.7) 0.55
Days to seek care 3.1 (2.0) 2.9 (2.1) 0.07
Days to recoveryβ 50.4 (58.3)
Pain intensity at event (%)
Moderate 60 (35.5) 255 (38.7) 0.02
Severe 77 (45.6) 330 (50.1) 0.02
Very Severe 32 (18.9) 74 (11.2) 0.02
Occupation n (%)
Unemployed 24 (14.0) 118 (17.9) 0.01
Clerical and Administrative Worker 16 (9.4) 64 (9.7) 0.01
Community and Personal Service Worker 8 (4.7) 34 (5.2) 0.01
Labourer 6 (3.5) 19 (2.9) 0.01
Machinery Operator and Driver 3 (1.8) 20 (3.0) 0.01
Manager 30 (17.5) 102 (15.5) 0.01
Professional 67 (39.2) 216 (32.7) 0.01
Sales worker 4 (2.3) 36 (5.5) 0.01
Technician and Trade Worker 13 (7.6) 51 (7.7) 0.01
Physical activity participation level (total MET minutes/week)
1 week before event 2,034 (2,499) 1,892 (2,452) 0.45
Week of event 1,245 (2,488) 1,281 (2,451) 0.81
12 months after event 1,626 (2,472) 1,851 (2,471) 0.23
‡Bold denotes significance at the 0.05 level
α - Time elapsed between the date of pain onset and the date of the baseline interview
β - Time elapsed between the date of pain onset and the date of reported recovery.
https://doi.org/10.1371/journal.pone.0219556.t001
Table 2. Difference in physical activity level (total MET minutes per week) before the onset of low back pain within group among multiple time-points.
Pre-pain physical
activity participation
Physical activity participation
1 week after index episode
Change from pre-pain
levels of physical
activity
Physical activity participation
12 months after index episode
Change from pre-pain
levels of physical
activity
Persistent pain
group (SD)/(95%
CI)
2,034 (2,499) 1,245 (2,488) -788.3 (-990 to -585);
p<0.001
1,626 (2,472) -407.3 (-822 to 8.38);
p = 0.055
Recovered group
(SD)/(95% CI)
1,892 (2,452) 1,281 (2,451) -611.1 (-723 to -498);
p<0.001
1,851 (2,471) -41.1 (-300.6 to 218.3);
p = 0.756
Between-group
difference (95% CI)
141 (-508.1 to 224.8);
p = 0.449
35.6 (-257.1 to 328.3);
p = 0.812
- 224.5 (-144.5 to 593.6); p = 0.233 -
Bold denotes significance at the 0.05 level.
https://doi.org/10.1371/journal.pone.0219556.t002
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95% CI 0.99 to 1.00; p = 0.923) (Table 3). The results of unadjusted logistic regression models
are presented in Table 4.
Fig 2. Mean total MET minutes per week at each time-point. p value> 0.05 for all comparisons.
https://doi.org/10.1371/journal.pone.0219556.g002
Table 3. Association between physical activity level (total MET minutes per week) before index episode and the
presence of low back pain 3 months and 12 months after the index episode.
Presence of pain� Physical Activity Level
Odds Ratio 95% CI Lower limit 95% CI Upper limit P value
3 months 1 0.99 1.01 0.92
Age (years) 1 0.99 1.01 0.94
Gender (Male) 0.72 0.49 1.06 0.09
BMI (kg/m2) 0.96 0.92 0.99 0.04
Pain intensity at index episode 0.91 0.83 0.99 0.03
12 months 0.99 0.99 1.00 0.52
Age (years) 1 0.99 1.01 0.42
Gender (Male) 1.11 0.88 1.39 0.37
BMI (kg/m2) 1 0.99 1.03 0.41
Pain intensity at index episode 1.06 1.01 1.12 0.02
�Both analyses were adjusted for age, gender, BMI, pain intensity at index episode, depression, anxiety and
occupation. Bold denotes significance at the 0.05 level.
https://doi.org/10.1371/journal.pone.0219556.t003
Physical activity and acute low back pain
PLOS ONE | https://doi.org/10.1371/journal.pone.0219556 July 10, 2019 8 / 12
103
Discussion
Our results have shown that the self-reported level of physical activity participation before
pain onset was not associated with recovery 12 months following the index episode, after
adjusting for age, gender, BMI, depression and pain intensity at index episode. In fact, pre
pain levels of physical activity were similar for those who developed persistent pain, compared
to those who recovered within 12 months from index episode. Similar results were also
observed for those who had recovered by 3 months after index episode. Our results also dem-
onstrated that, although there is a sharp reduction in physical activity participation in the first
week after the index episode, most people reached similar pre-pain levels of physical activity
12 months after index episode.
Our study used a large inception cohort where participants were included near or soon
after the onset of symptoms. Also, our sample had a low exclusion rate (11.9%), mainly due to
low pain intensity, suggesting ours was a representative sample of the population seeking med-
ical attention for an acute episode of low back pain. We acknowledge however, that this was a
physically active cohort, and only 17.4% of participants were considered inactive before pain
onset, according to IPAQ-SF classification score [28]. This suggests our cohort was, on aver-
age, more active than the general population, with a weekly mean of 449 (SD 544) minutes of
physical activity participation (over 60 minutes per day) versus the mean 39 minutes per day
observed in the general population [29]. Typically, our cohort was also relatively young (45.3
years), most of them employed as clerical and administrative workers, community and per-
sonal service workers, managers or sales workers (84%). It is possible that our study population
was more health literate and, therefore, more aware of the benefits of regular physical activity
participation.
Our findings agree with the results of a systematic review assessing the relationship between
physical activity and pain and disability including measures of recovery and reoccurrence of
low back pain [30]. The authors included 12 studies (seven cohort and five cross-sectional) in
their analyses (n = 3,979) to assess the role of habitual physical activity engagement on disabil-
ity scores or pain levels and found no support on the literature on the association of physical
activity and non-specific low back pain outcome measures. These findings support our results
of no significant association between physical activity levels and the outcomes, recovery or
reoccurrence of low back pain. Our study adds to the body of evidence relating the self-
reported level of physical activity engagement to low back pain by following a sample of
enough size and with long term follow-up data collections to assess the predictive value of the
self-reported level of physical activity engagement for recovery after an acute episode of low
back pain.
Although physical activity participation was not found to be associated with recovery from
a low back pain episode, when taking into consideration the benefits linked to regular physical
activity participation it is likely that avoiding bed rest and remaining as physically active as
possible should continue to be recommended as the management of low back pain. Also,
based on our results it is safe to say that engagement in physical activities did not cause further
Table 4. Association between physical activity level (total MET minutes per week) before index episode and the
presence of low back pain 3 months and 12 months after the index episode (unadjusted analysis).
Presence of pain Physical Activity Level
Odds Ratio 95% CI Lower limit 95% CI Upper limit P value
3 months 1 1 1 0.77
12 months 1 1 1 0.56
https://doi.org/10.1371/journal.pone.0219556.t004
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harm, supporting the current recommendation that participants should avoid bed rest and try
to resume their activities routines as soon as possible [31].
Study limitations
Our study presents some limitations that need to be considered when interpreting the results. For
instance, 17% of participants were lost to follow-up due to unavailability to respond or declining
to participate in the study. We also acknowledge that physical activity participation was ascer-
tained via questionnaire. There is evidence suggesting that self-reported measures of physical
activity participation result in overestimation of participation when compared to accelerometer-
based data, especially in cohorts with moderate to high intensity physical active routines [32]. The
Active Australia questionnaire also relies on recall, as participants were asked about their level of
physical activity on the week before the interview; however, short recall periods of up to 2 weeks
are reported as less susceptible to recall bias [21]. This could be a potential source of bias since the
perception of pain could lead the participants to change their perceptions of how much physical
activity they performed on the week prior to the pain, however, despite the maximum recall time
possible in our study being of up to 3 weeks, the actual mean recall time was of only 5 days [13].
Due to the high variability of the physical activity measurement and the recall bias, these could
have biased the results of the assessed associations towards the null.
Conclusion
Our study has shown that, regardless of the self-reported level of physical activity participation
before an episode of acute low back pain, and whether or not they have recovered from pain at
12 months, participants with low back pain tend to return to the pre-pain self-reported level of
physical activity. Moreover, physical activity participation before pain onset is not a significant
predictor of recovery among people with an acute onset of low back pain.
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CHAPTER SIX 
Complications for low back pain and sciatica admissions: a population-based cohort study 
Chapter Six is presented as a traditional thesis chapter. 
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Summary 
Objective: The aim of this study was to ascertain the impact of cardiovascular, 
cerebrovascular, respiratory or renal comorbidities on the odds of complications after 
hospital admissions for low back pain and sciatica. Design: This is a retrospective study of 
hospital admissions for low back pain and sciatica in New South Wales, Australia between 
2003 and 2013. Patient data were ascertained via the Admitted Patient Data Collection and 
obtained from the Centre for Health Record Linkage (CHeReL). Eligible episodes of care were 
included based on principal diagnosis. The therapeutic procedures were grouped into spinal 
fusion, surgical decompression, spinal injection, and non-surgical care. Complications were 
categorised into major complications (e.g. cardio respiratory arrest, acute myocardial 
infarction, stroke, and death), mild to moderate complications (e.g. sequelae of injuries, 
wound infections and poisoning), and adverse outcomes (e.g. noninvasive ventilatory 
support, central vein catheterization and transfusion of leukocytes). Comorbidities were 
classified as cardiovascular, cerebrovascular, respiratory or renal. A multiple logistic 
regression model was conducted to assess the impact of comorbidities on the odds of 
complications after procedures for low back pain and sciatica. The model included person 
(i.e. age, sex, diagnosis and comorbidities) and health care (i.e. public or private hospital, 
main procedure performed) characteristics as covariates. Results: A total of 82,100 
admissions of unique patients were identified between 2003 and 2013. Overall, 10,612 
patients (12.9%) experienced at least one complication, the majority of them (n= 7,277) 
being categorized as an adverse outcome. Our multivariate logistic regression analysis 
showed that pre-existing cardiovascular, respiratory, or renal comorbidities were 
independently associated with all categories of in-hospital complications after health care 
interventions for low back pain and sciatica. Patients with respiratory comorbidities had the 
highest odds of experiencing complications compared to patients without comorbidities OR 
2.00 (1.78 to 2.26; p <0.001), irrespective of the therapeutic procedure received. 
Conclusion: The presence of pre-existing comorbidities is associated with twice the odds of 
complications irrespective of the hospital procedure performed for the care of low back 
pain with or without sciatica. 
Keywords: hospitalization; complications; low back pain, sciatica. 
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INTRODUCTION 
Low back pain is a costly condition worldwide [1] affecting one in 5 people globally at any 
given time [2]. It Is the 10th most common reason for hospital admissions in the USA, 
resulting in 2.7% (US$ 30 billion) of its annual health care expenditure [3]. The main reason 
for hospital admission among people with low back pain is to undergo advanced and 
invasive medical procedures such as spinal fusion, spinal decompression, or epidural 
glucocorticoid injection [4]. With an average of AUD$ 13,500 spent per surgical procedure, 
and approximately 87,000 procedures being performed every year in Australia only, this 
practice results in an expenditure of over AUD$ 1 billion every year [5]. These costs can be 
substantially greater when complications occur [6]. 
The number of complex invasive procedures performed for low back pain increased 
substantially (i.e. 15 times) in the USA between 2002 and 2007 [7]. These procedures may 
be associated with different levels of complications and adverse outcomes ranging from 
wound infections to cardiovascular events and death [8-10]. With the steady increase in 
invasive procedures and hospitalisations for low back pain over the years, there is therefore 
concern about the potential for a substantial rise in the number of related complications. 
Past studies have identified important predictors of complications of hospital care for low 
back pain [8, 11-15]. For example, there is evidence that men are at a higher risk of post-
surgical mortality compared to women after lumbar spinal stenosis and lumbar spinal fusion 
surgeries [15], and being overweight can double the risk of post-operative complications 
after lumbar fusion and decompression surgery [13]. Likewise, being admitted to a teaching 
hospital for low back pain increased 1.8, 2.3, and 4 times the risk of pulmonary embolism, 
deep vein thrombosis, and infection, respectively, compared to being admitted to a non-
teaching hospital [8]. The relationship between being admitted to a teaching hospital and 
risk of complications could be related to geographical differences and experience of medical 
staff. Patients admitted to a teaching hospital were older, presented worse comorbidity 
scores, and were admitted for longer periods when compared to those admitted at private 
hospitals [8]. However, studies on the role of co-existing chronic diseases (e.g. heart 
diseases, cerebrovascular diseases, and chronic pulmonary disease) on the odds of 
complications for inpatient care of low back pain and sciatica are scarce. 
111
The primary aim of this study was to ascertain the association of having a comorbidity on 
the odds of hospital complications during admissions for low back pain and sciatica, when 
adjusted for person-level (i.e. age, sex, and primary diagnosis) and health care-level (i.e. 
public or private hospital and source of referral) characteristics. 
 
METHODS 
Study design 
This is a retrospective study conducted using data from New South Wales Admitted Patient 
Data Collection (APDC) with a linked data analytic approach. Admitted patient data 
regarding the interventions were categorised into four therapeutic procedures for low back 
pain or sciatica: spinal fusion, spinal decompression, spinal injection, and non-surgical care 
(the complete list of procedure codes included in each category is described in the 
supplementary file). Data related to the patient’s comorbidities of interest were grouped 
into four categories: cardiovascular, cerebrovascular, respiratory, or renal comorbidities. 
 
Data Source 
The APDC was used to identify hospital admissions for low back pain and sciatica between 
2003 and 2013, and provides information on person-level factors (i.e. age, sex, marital 
status, diagnosed comorbidities) and health care characteristics (i.e. health area of the 
hospital, type of hospital, source of referral and length of stay) for each episode of care. This 
period of time was chosen due to data availability. The chosen period of 10 years is not 
believed to have been affected by any early trend. The study was approved by the NSW 
Population and Health Services Research Ethics Committee (HREC/14/CIPHS/65). Patients’ 
admittance data was ascertained by the Centre for Health Record Linkage (CHeReL) using 
probabilistic linkage methods. 
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Study Population 
Eligible episodes of care were identified based on principal diagnosis and therapeutic 
procedure. Patients with principal diagnosis of low back pain or sciatica were selected based 
on the International Statistical Classification of Diseases (ICD) and Related Health Problems, 
10th Revision, Australian Modification (ICD-10-AM) codes M51.1 (thoracic, thoracolumbar 
and lumbosacral intervertebral disc disorders with radiculopathy), M51.2 (other thoracic, 
thoracolumbar and lumbosacral intervertebral disc displacement), M54.3 (sciatica), M54.4 
(lumbago with sciatica), M54.5 (low back pain) for admission. Patients with a principal 
diagnosis of cancer, injury due to motor vehicle accident, spinal infection, spinal cord injury, 
inflammatory diseases of the spine, or cervical and thoracic related diagnoses were 
excluded. 
 
Predictors 
Comorbidities of interest were identified using the ICD codes for additional diagnoses 
registered on admission, and classified into four major groups: cardiovascular, 
cerebrovascular, respiratory, or renal comorbidities. 
 
Person-level and health care-level covariates 
Covariates for this study were selected based on data availability and potential association 
with both predictors and outcomes. Person-level covariates were age, sex, and primary 
diagnosis. 
Health care-level covariates included type of hospital (e.g. public or private) and source of 
referral (e.g. hospital in the same Health Service, Other Hospital/Day Procedure Centre, and 
Nursing Home/Residential Aged Care Facility). Patients referred from other health care units 
(e.g. other hospitals, residential aged care facility, mental health, emergency department or 
unknown type) were classified as ‘transferred’ [16]. 
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Therapeutic procedures 
The therapeutic procedures of the lumbar spine with more than 100 occurrences over the 
assessed period (10 years) were identified based on the principal procedure of the episode 
of care and classified according to the Australian Classification of Health Interventions 
(ACHI) 8th edition. The identified procedures were pooled into the categories spinal fusion, 
spinal decompression, spinal injection and non-surgical care, which included dietetics, social 
work, occupational therapy and physiotherapy. 
 
Study Outcomes 
Complications were identified using the International Statistical Classification of Diseases 
and Related Health Problems, 10th Revision, Australian Modification (ICD-10-AM) codes. All 
complications were categorised into major complications, mild to moderate complications 
or adverse outcomes based on discharge reports. Major complications included 
cardiorespiratory arrest, acute myocardial infarction, respiratory failure, pulmonary 
embolism, pneumonia, stroke, and death. Mild to moderate complications were 
complications affecting patients during surgical and medical care related to medical devices, 
sequelae of injuries, wound infections, poisoning and other consequences of external 
causes, or surgical and other medical procedures. Adverse outcomes were defined as those 
harmful events not included in the above mentioned categories and included non-invasive 
ventilatory support, central vein catheterization, continuous monitoring of pulmonary 
function for a period equal or over 6 hours and intermittent peritoneal dialysis. 
 
Statistical analysis 
Descriptive analysis of person-level factors, health care characteristics, and rate of 
complications was presented for each therapeutic procedure group, including means and 
standard deviations (SD) for continuous variables, and frequencies and proportions (%) for 
categorical variables. The association between each potential covariate and the outcome 
was assessed in bivariable analyses. Covariates which showed a significant association with 
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the outcome (p ≤0.2) were included in multivariable regression analyses [17, 18]. A 
multivariable logistic regression adjusted by covariates was conducted to ascertain the 
association between each type of comorbidity and complications by procedures. Adjusted 
odds ratio (OR), 95% confidence intervals (CIs), and corresponding p values were reported. 
All significant tests were 2-sided, with an alpha of 0.05. The statistical analyses were 
performed using STATA statistical software (StataCorp. 2015. Stata Statistical Software: 
Release 14. College Station, TX: StataCorp LP). 
 
RESULTS 
A total of 82,100 admissions of unique patients with low back pain or sciatica diagnoses 
were identified from the APDC database between 2003 and 2013. On average, participants 
were 56.7 (SD 17.8) years of age, similar sex distribution (51% female) and approximately 
half of the sample were admitted with a principal diagnosis of sciatica (51.3%). The most 
common comorbidity in the sample was cardiovascular disease, with 7.5% of the sample 
reporting coexisting cardiovascular disease; followed by renal comorbidities (2.6%) and 
respiratory comorbidities (2.1%). Age was found to be a statistically significant but weak 
predictor of hospital complications (OR 1.003; 95% CI 1.002 to 1.004; p <0.001). 
 
Among the 82,100 hospital admissions, 50,371 (61.3%) occurred at private hospitals. 
Approximately 80% of admissions for spinal fusion (n= 3,428; 83.8%) occurred at a private 
hospital, whilst less than 20% of the admissions for non-surgical care (n = 3,632; 17.1%) 
were in the private setting. Approximately one quarter of admitted patients (n=21,764, 
26.5%) was transferred from another hospital, most of whom (n=17,226, 79%) were 
admitted for non-surgical care. On average, the length of stay for low back pain or sciatica 
was 4 days (SD 5.1). Table 1 presents data on person-level and health care characteristics, 
and complications per therapeutic procedure for all participants. 
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Procedures 
The most frequent therapeutic procedure for admitted patients with low back pain was 
non-surgical care (n=14,677), followed by spinal injection (n=14,542) and spinal 
decompression (n=8,593). For patients admitted with a diagnosis of sciatica the most 
frequent procedure was spinal decompression (n=24,881), followed by spinal injection 
(n=8,737) and conservative care (n=6,579) (table 1). 
 
Complication rates 
Overall, 10,612 patients (12.9%) experienced at least one complication, of whom 332 
patients reported two different complications and 10 patients reported three (table 1). A 
total of 991 (24.2%) of the 4,091 patients undergoing spinal fusion experienced at least one 
hospital complication, whereas 5,030 of the 33,474 patients undergoing surgical 
decompression (15%) reported a hospital complication (table 1). Similarly, a total of 2,047 
patients (8.8%) admitted for a spinal injection and 2,184 patients (10.2%) admitted for non-
surgical care reported one hospital complication and a total of 564 in-hospital deaths were 
registered (table 1). 
The most common complication experienced by patients undergoing spinal fusion was mild 
to moderate complications (e.g. haemorrhage, wound infection, inflammation) (14.2%). 363 
patients experienced an adverse outcome following spinal fusion (table 2). 
 
Association between presence of comorbidities and hospital complications 
Our multivariable logistic regression results have demonstrated that, when adjusting for 
diagnosis, sex, age, hospital type and procedure performed, having a cardiovascular 
comorbidity will increase the overall odds of any complication by over one third (OR: 1.40; 
95% CI 1.30 to 1.51; p <0.001) (table 2). For those with a respiratory comorbidity these odds 
will double (OR: 2.00; 95% CI: 1.78 to 2.26; p <0.001) and the odds will increase 67% for 
those with a renal comorbidity (OR: 1.67; 95% CI: 1.47 to 1.89; p <0.001) (table 2). 
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The impact of each covariate on the odds of complications is described in detail on table 2. 
 
DISCUSSION 
The aim of this study was to ascertain the odds of complications or adverse outcomes 
associated with coexisting chronic conditions, restricted to cardiovascular, cerebrovascular, 
respiratory or renal diseases. We also assessed if that association was independent of 
selected person-level and health care-level characteristics including age, sex, diagnosis, type 
of hospital and the therapeutic procedure performed during a hospitalisation. We included 
over 82,000 unique admissions for low back pain and sciatica between 2003 and 2013. The 
study period was chosen based on data availability. Our study findings indicate that low 
back pain and sciatica patients who are admitted to hospital have, in general, low to 
moderate levels of complications or adverse outcomes. However the odds of presenting 
major complications were significantly higher (i.e. two times more likely) in the presence of 
pre-existing respiratory conditions. 
A number of comorbidities have been identified in low back pain populations with a 
negative influence on treatment outcomes, for example, hypertension [19], atherosclerosis 
[20], depression [21], congestive heart failure [22], and obesity [20, 21]. Low back pain 
patients with obesity have increased odds of developing complications after lumbar surgical 
procedure compared to normal weight patients [13]. Mannion et al. also found that the 
presence of comorbidities assessed using the American Society of Anaesthesiologists (ASA) 
comorbidity grade (e.g. normal healthy, mild/moderate systemic disease, severe or life-
threatening) is associated with increased odds of surgical complications and general 
complications in patients admitted for lumbar spinal surgery (OR 1.56; 95% CI 1.29 to 1.88; 
p<0.0001 and OR 1.78; 95% CI 1.47 to 2.17; p<0.0001, respectively) [23]. Similarly, our 
results show that the presence of comorbidities increase the odds of having any 
complication by at least one third. The most strongly associated comorbidity with the odds 
of complications of hospital care for low back pain and sciatica was respiratory disease. This 
was observed irrespective of the diagnosis, therapeutic procedure performed, age, sex or 
type of hospital for the episode of care. 
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Our results are in line with the findings from the study Schoenfeld et al. conducted analysing 
medical records of 5,885 patients undergoing spinal surgery over a 5 years period. The 
authors found that patients undergoing surgery with pulmonary conditions have increased 
odds of presenting post surgical complications and death (OR 1.7; 95% CI 1.2 to 2.4; p=0.003 
and OR 4.6; 95% CI 1.7 to 11.9; p=0.002, respectively) [24]. Studies also found a significant 
correlation between comorbidity scores measured by the Charlson Comorbidity Index (CCI) 
and the likelihood of minor complications (p=0.0032) and the American Society of 
Anesthesiologists Physical Status Classification System (ASA grade) and the likelihood of 
major complications (p=0.0035) after surgical interventions on the spine [25]. 
The current study has some limitations. The APDC dataset does not record symptom 
information (i.e. pain intensity, pain duration, nerve impairment), nor does it record 
psychosocial status, which is considered a relevant prognostic factor of low back pain. The 
lack of these data may bias the results found in the analyses. Retrospective studies based on 
routinely collected data have limitations due to the potential for miscoding. We have used 
the principal diagnosis code and the principal procedure of the episode of care code to 
ensure the correct classification of low back pain and sciatica patients. The data were 
analysed by the episode of care which means that the same patient could be reported more 
than once. Despite these limitations, the results presented here provide important 
estimates of inpatient complications after low back pain and sciatica admissions. 
 
CONCLUSION 
Therapeutic procedures related to low back pain and sciatica are associated with 12.9% 
rates of complications or adverse outcomes. The presence of comorbidities, especially 
respiratory and cardiovascular conditions, will increase significantly the odds of 
complications or adverse outcomes during the hospitalisation for low back pain and sciatica. 
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Table 1 – Person-level factors, health care characteristics, and complications for low back pain and sciatica admissions in NSW Australia 
between 2003 and 2013. 
 Spinal Fusion 
(n=4,091) 
Decompression 
(n=33,474) 
Spinal Injection 
(n=23,279) 
Non-surgical care 
(n=21,256) 
Total 
(n=82,100) 
Person-level factors     
Age – mean (SD) 53.1 (14.7) 50.3 (15.5) 58.6 (16.1) 65.3 (19.4) 56.7 (17.8) 
Sex (Female) – n (%) 1,975 (48.3) 14,397 (43.0) 12,613 (54.2) 12,929 (60.8) 41,914 (51) 
Principal Diagnosis - n 
(%) 
     
Low Back Pain 2,139 (52.3) 8,593 (25.7) 14,542 (62.5) 14,677 (69) 39,951 (48.7) 
Sciatica 1,952 (47.7) 24,881 (74.3) 8,737 (37.5) 6,579 (31) 42,149 (51.3) 
Comorbidities - n (%)      
Cardiovascular 533 (13.0) 2,786 (8.3) 1,258 (5.4) 3,124 (14.7) 7,701 (9.4) 
Cerebrovascular 7 (0.2) 36 (0.1) 22 (0.1) 199 (0.9) 264 (0.3) 
Respiratory 144 (0.3) 636 (1.9) 199 (0.8) 969 (4.5) 1,948 (2.4) 
Renal 79 (1.9) 305 (0.9) 161 (0.7) 1,595 (7.5) 2,140 (2.6) 
Health care characteristics     
Hospital Type (Private) - 
n (%) 
3,428 (83.8) 25,437 (76) 17,874 (76.8) 3,632 (17.1) 50,371 (61.3) 
Source of Referral 
(Transferred) - n (%) 
89 (2.2) 2,521 (7.5) 1,924 (8.3) 17,202 (80.9) 21,735 (26.5) 
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Length of stay (days) – 
mean (SD) 
7.4 (5.2) 4.5 (4.2) 2.0 (3.8) 5.9 (6.6) 4.3 (5.1) 
Costs (mean, AUD) 27,147 9,299 978 4,152 1,624 
Deaths – n (%) 25 (0.6) 225 (0.7) 152 (0.6) 162 (0.8) 564 (0.7) 
Complications - n (%) 991 (24.2) 5,030 (15) 2,407 (10.3) 2,184 (10.3) 10,612 (12.9) 
Major Complications 46 (1.1) 271 (0.8) 156 (0.7) 168 (0.8) 641 (0.8) 
Mild to moderate 
Complications 
582 (14.2) 1,825 (5.5) 120 (0.5) 167 (0.8) 2,694 (3.3) 
Adverse outcomes 363 (8.9) 2,934 (8.8) 2,131 (9.1) 1,849 (8.7) 7,277 (8.9) 
None 3,063 (74.9) 28,136 (84) 21,682 (93.1) 18,877 (88.8) 70,758 (86) 
Frequency (%) for categorical variables and mean (SD) for continuous variables. 
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Table 2 – Odds of complications according to pre-existing comorbidities after healthcare 
procedures, compared to patients with no comorbidity. 
Comorbidity Complications 
    Cardiovascular 1.40 (1.30 to 1.51; p <0.001) 
    Cerebrovascular 1.31 (0.86 to 1.99; p =0.201) 
    Respiratory 2.00 (1.78 to 2.26; p <0.001) 
    Renal 1.67 (1.47 to 1.89; p <0.001) 
Procedure  
    Non-surgical Reference group 
    Spinal Fusion 2.89 (2.63 to 3.18; p <0.001) 
    Spinal Decompression 1.74 (1.62 to 1.86; p <0.001) 
    Spinal Injection 1.17 (1.09 to 1.26; p <0.001) 
Diagnosis (LBP) 1.01 (0.96 to 1.06; p =0.70) 
Sex (female) 1.02 (0.98 to 1.06; p =0.33) 
Age 1.003 (1.002 to 1.004; p <0.001) 
Hospital Type (private) 0.96 (0.91 to 1.01; p =0.131) 
  
* All analyses were adjusted for procedure, pain type, sex, age and hospital type. 
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Supplementary file 
 
Diagnosis codes: 
 
Group 1. Spine Fusion - 48648-00; 48651-00; 48654-00; 48654-01; 48657-00; 48657-01; 
48660-00; 48669-00; 48678-00; 48681-00; 48684-00. 
 
Group 2. Decompression - 40300-00; 40303-00; 40330-00; 40330-01; 90024-00; 90024-01. 
 
Group 3. Spine injection - 18216-00; 18216-06; 18216-27; 18230-00; 18230-01; 18274-02; 
18274-03; 18276-00; 18286-01; 18292-00; 18296-00; 22035-03; 39013-00; 39140-00; 
50124-01; 90018-00; 90019-00; 90028-00 
 
Group 4. Non-surgical care - 95550-00; 95550-01; 95550-02; 95550-03 
 
124
  
 
 
 
 
 
CHAPTER SEVEN 
 
 
Conclusion 
 
 
125
CHAPTER SEVEN - Conclusion 
Overview of principal findings 
The main aim of this thesis was to investigate the role of specific contextual factors, namely 
obesity, sex, diabetes, level of physical activity and existing comorbidities on the prevalence, 
prognosis and management of musculoskeletal pain. These factors were chosen due to their 
influence on the burden on healthcare systems in today’s society, known relevance in 
epidemiological research or data availability for our research purposes. 
The systematic review presented in Chapter Two has identified obesity as an important predictor 
of surgical outcomes (i.e. pain, disability, complications and quality of life) for hip and knee joint 
replacements due to osteoarthritis. This systematic review with meta-analysis of cohort studies 
identified that patients with pre-surgical obesity (i.e. BMI≥30 kg/m2) have worse pain and 
disability after surgery compared to normal weight patients. They also have higher odds of 
developing post-surgical complications (i.e. implant dislocation, deep vein thrombosis and 
revision surgeries) when compared to non-obese patients (i.e. BMI<30 kg/m2). 
The twin-controlled study presented in Chapter Three showed that, when genetics and early 
environment are adjusted for, women are not more likely than men to report low back pain, 
therefore challenging the view that women are more likely to develop low back pain compared to 
men. Women are, however, more likely to seek care for low back pain and report limitations in 
daily activities due to low back pain, compared to men with low back pain.  
Coexisting metabolic and cardiovascular comorbidities are known to be important predictors of 
poor outcome in people with musculoskeletal pain. Chapter Four presents the results of a 
systematic review conducted to ascertain whether diabetes is associated with low back pain or 
neck pain. The cross-sectional analyses showed that people who seek health care for diabetes are 
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almost 3 times more likely to present spinal pain, compared to non-diabetic subjects. No causal 
relationship between the two conditions could be established, however. Diabetes is a condition 
strongly linked to physical inactivity and obesity [1, 2], and it is likely that these, as well as other 
lifestyle factors, such as smoking [3, 4], moderate the link between diabetes and low back pain. 
To date, little is known about the direct pathway that could link pre-pain physical activity 
participation and likelihood to recover from low back pain. The study presented in Chapter Five 
showed that, after adjusting for age, sex, BMI, depression and pain intensity self-reported level of 
physical activity participation before pain onset was not associated with recovery 12 months 
later. 
Chapter Six focussed on hospital complications for low back pain and sciatica and their 
association with pre-existing comorbidities. In particular, people with cardiovascular 
comorbidities have a 34% increasing in the overall risk of complications while in hospital. For 
patients with respiratory or renal comorbidities the risk is increased by 84% and 56%, 
respectively. 
The work presented in this thesis reports the association between common conditions, such as 
diabetes, and musculoskeletal pain and the effect that different contextual factors have on the 
prevalence, prognosis and management of musculoskeletal pain. This thesis presents new 
evidence that challenges the current view that women are more likely to develop low back pain 
than men. The work reported in this thesis has implications for health care professionals and 
future research addressing musculoskeletal pain, especially regarding risk, prognosis and 
management of osteoarthritis and low back pain. 
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Implications and directions for future research 
This thesis provide evidence that people who are obese may not benefit as much from surgical 
management for hip and knee osteoarthritis, as shown in Chapter Two. As obesity is expected to 
increase worldwide, future research should focus on identifying whether obesity interacts with 
surgical treatment in randomised controlled trials. This would inform whether different 
subgroups of people with osteoarthritis, based on BMI levels, would respond differently to joint 
replacement. 
Sex seems to determine care seeking behaviour but not prevalence of low back pain. My work 
presented on Chapter Three of this thesis provides evidence that these differences in care 
seeking for low back pain may affect the design of randomised controlled trials and cohort 
studies, given women are likely to be overrepresented when being recruited from clinical 
settings, compared to community settings. These different proportions, however, are not 
necessarily representative of the true association between sex and prevalence of low back pain.  
The relation between type 2 diabetes and spinal pain has long been controversial. My work 
presented on Chapter Four has established a strong and statistically significant association 
between these two conditions. Low back pain may be a reason stopping people with diabetes 
from exercising and this will affect treatment of both conditions. We still do not understand 
clearly how they are linked. If the two conditions are linked by common inflammatory pathways, 
a common medication could be developed to address this underlying common origin. The role of 
medication for glycaemic control in the relation between diabetes and low back or neck pain also 
needs to be better understood. 
Physical activity engagement is an important strategy in controlling the development of new 
episodes of low back pain. Chapter Five presents evidence that physical activity does not seem to 
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be associated with a person’s likelihood to recover from a future episode, despite  the numerous 
health benefits provided by regular engagement in physical activity. 
The results presented on Chapter Six reveal that existing cardiovascular, respiratory or renal 
comorbidities are associated with higher odds of complications during hospital admissions for low 
back pain or sciatica. 
Considering the applicability of the findings of this thesis to guide best practice and future 
research, several key topics will now be considered. 
 
Obesity and Osteoarthritis surgery prognosis 
The results of Chapter Two suggest that obesity needs to be considered by health professionals 
when recommending knee or hip arthroplasty, given its association with higher risk of 
complications, worse pain and disability. It is proposed that overweight and obese individuals 
undergoing knee or hip arthroplasty may experience better results if they engage in a more 
intense multidisciplinary rehabilitation program before surgery. Weight control programs must be 
effectively implemented in overweight and obese people suffering from end stage osteoarthritis 
and needing hip or knee joint replacement surgeries. Since end stage osteoarthritis is 
characterized by disabling joint pain and loss of function, these programs should focus on dietary 
management and low impact and low weight load bearing exercises (e.g. aquatic therapy and 
swimming) to decrease risks of complications and improve prognosis. Future research should also 
focus on studies assessing the association between physical activity and the surgical outcomes of 
hip or knee osteoarthritis. 
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Sex and low back pain prevalence 
Chapter Three presents results from co-twin control analyses of the prevalence of low back pain 
between sexes on twin pairs opposite for sex and discordant for low back pain using data from 3 
twin registries. The analyses showed consistent results of no association of sex and prevalence of 
low back pain either when considering each registry separately or when merging all registries into 
a single dataset. The results did not change either when considering all participants as single 
individuals or when conducting the co-twin control analyses, therefore adjusting for genetics and 
early shared environment. However, according to our analyses, men are less likely to seek care 
for low back pain when compared to women. 
Future research should focus on using standardized questionnaires to make the merging process 
easier and more reliable. This would allow merging of data from different sources with higher 
accuracy, and minimize the influence of regional behavioural differences. Future research should 
also aim to assess whether women present more physical limitations and therefore seek more 
care for low back pain or whether they are more likely to report physical limitations compared to 
men. 
 
Diabetes and Spinal Pain 
Chapter Four presents evidence from a systematic review and meta-analysis that people with 
type 2 diabetes are more likely to report neck and low back pain (separately or concurrently) at 
both short and long term when compared to subjects without type 2 diabetes. Current evidence 
states that diabetes is strongly correlated with other joint disease (e.g. adhesive capsulitis or 
frozen shoulder), however the true mechanism behind this association remains unclear [5]. One 
known consequence of diabetes is the increase in the accumulation of advanced glycation end 
products in the spinal disc and these are related to accelerate spinal disc degeneration [6, 7]. 
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Also, elevated glucose concentration (another common instance in uncontrolled diabetes) can 
have a negative effect on the spinal disc regeneration [8]. These facts suggest that the metabolic 
alterations caused by uncontrolled diabetes may result in spinal disc degeneration [6] and, 
consequently, low back pain. 
Recent studies also present evidence that people with diabetes who have knee osteoarthritis 
experience significantly more intense pain and greater radiographic progression when compared 
to non-diabetic persons also with knee osteoarthritis [9, 10]. Synovial inflammation is prevalent in 
osteoarthritis, suggesting that pain in osteoarthritis may be inflammation driven [11, 12]. 
However the specific inflammatory pathways of pain development in osteoarthritis remain 
unclear [9]. The mechanisms underlying the association between diabetes and joint pain (e.g. low 
grade systemic inflammation, sensory neuropathy and vascular complications), as well as the 
design of interventions considering both health conditions, should be considered in future 
research to improve management of musculoskeletal pain. 
Future research addressing the association between diabetes and spinal pain should also consider 
the effects of diabetes medication on musculoskeletal pain, especially using longitudinal designs 
and large, representative samples. Duration of diabetic symptoms and use of medication should 
also be included in the analyses as these can be important confounders of the relationship 
between spinal pain and diabetes. 
 
Level of physical activity and recovery from back pain 
The results of Chapter Five show that, after adjusting for known confounders such as age, sex, 
BMI, depression and pain intensity, the level of physical activity participation before an episode of 
acute low back pain is not associated with recovery at 12 months follow-up. These results are in 
accordance with the findings from a previous prospective cohort study that found no evidence 
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supporting the relationship between pre-pain levels of physical activity and outcomes of low back 
pain, including recovery 3 months after the pain episode [13]. Chapter Five results strengthen the 
body of evidence by using a large sample and longer term follow up. 
Future studies should adopt a different strategy to assess physical activity engagement (e.g. 
accelerometer) to avoid any bias associated with self-reported. This would have the added 
benefit of reducing the risk of recall bias, since the data would be directly and objectively derived 
from device measurements. 
 
In-hospital complications in patients with low back pain or sciatica 
Through analysis of medical record data, the study reported in Chapter Six presented evidence 
that existing comorbidities increase the risk of having major hospital complications for people 
presenting with low back pain or sciatica. This study reported the risk of complications associated 
with existing cardiovascular, renal and respiratory comorbidities to be 36%, 60% and 88% higher, 
respectively, when compared to patients with no comorbidity. 
Future studies should aim to link medical records to data on psychosocial status and symptom 
information (e.g. pain intensity, pain duration), as these are considered relevant predictors of low 
back pain prognosis. Also, medical records are susceptible to bias due to miscoding and multiple 
diagnosis codes when the same patient has multiple health care consultations. 
 
Concluding remarks 
Obesity, sex, diabetes, level of physical activity and comorbidities are common contextual factors 
that may influence the course of musculoskeletal pain. My work has shown that pre-surgical 
obesity is associated with worse outcomes of hip or knee replacement surgeries. I have also 
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challenged the views that sex affects the prevalence of low back pain and provided novel and 
robust data that diabetes is associated with the prevalence of spinal pain. My work has 
characterised that the level of physical activity engagement before an acute episode of low back 
pain is not related to recovery from the pain 12 months after the episode and existing 
cardiovascular, respiratory and renal comorbidities are associated with increased risks of 
complications after spinal procedures on hospital admissions for treatment of low back pain or 
sciatica. 
The overall evidence presented in this thesis point that contextual factors are indeed associated 
with prevalence, prognosis and management of musculoskeletal pain and should be taken into 
consideration by health care professionals when dealing with conditions such as osteoarthritis 
and low back pain. 
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Review question
Is there an association between diabetes and neck and back pain?
 
Searches
We searched the following electronic databases: MEDLINE, CINAHL, EMBASE and Web of Science from
inception to September 2016. Hand searching was also conducted in reference lists of included articles and
identified reviews.
 
Types of study to be included
Cross-sectional, case-control, twin-control and cohort studies. Surveys that have been conducted in person,
by phone, internet, mail or a combination of these.
 
Condition or domain being studied
Back and neck pain, and diabetes are common disorders which negatively impacts both individual and
society. Previous research shows that the two conditions often co-occur and when they do, patients face an
especially troublesome situation given the combined symptomatic manifestation, the psychological distress
and physical disability that usually accompany them. It is still unclear, however, whether these two conditions
are in fact associated.
 
Participants/population
Studies including patients with the characteristics of interest (type I or type II diabetes and non-specific low
back pain, neck pain or both), older than 18 years of age, will be included in the systematic review.
 
Intervention(s), exposure(s)
Inclusion criteria: Cross-sectional, case-control, twin-control and cohort studies will be included in the review.
To be included, studies need to assess the association between type 1 or type 2 diabetes and non-specific
low back or neck pain.
Exclusion criteria: Studies will be excluded from this review if they: i) include types of pain other than neck or
back and do not present separate results for the symptom of interest; ii) include patients with serious
pathology of the spine (e.g., cancer, fracture, infectious bone disease); iii) include multiple diseases and do
not present separate results for association between diabetes and back and neck pain; and iv) are not
written in English. Randomized controlled trials will also be excluded , as well as reviews, single-case studies
and research conducted in animal models or those focusing on gestational diabetes.
 
Comparator(s)/control
Not applicable.
 
Context
 
Main outcome(s)
Association estimates of the relationship between neck or back pain and diabetes.
 
Additional outcome(s)
None.
 
Data extraction (selection and coding)
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A standardized data extraction form will be used by two independent reviewers (DP and LN) to extract data
on pain, diabetes and general demographic and anthropometric information from the selected papers and a
third author (MF) will resolve any disagreement. If necessary authors will be contacted and asked to provide
further information or complement the data reported in the paper.
 
Risk of bias (quality) assessment
Studies will be assessed according to:
- Sampling: at least one of the following: whole target population, randomly selected sample, or sample
stated to represent the population;
- Response rate: reasons for non-response described, non-responders described, comparison of responders
and non-responders or comparison of sample and target population given;
- Data collected the same way for all participants and in prospective studies at first and following data
collections;
– Outcome measures: questionnaire validated, tested for reproducibility;
– Assessment quality: at least one of the following: interview validated, tested for reproducibility;
– Power calculation shown and inclusion of enough participants to show end points.
 
Strategy for data synthesis
Estimates of association between back or neck pain and diabetes will be extracted from included studies in
any format supplied by the authors. Fisher’s z effect sizes and 95% confidence intervals for individual
studies will be calculated and pooled using the Comprehensive Meta-Analysis software.
 
Analysis of subgroups or subsets
Analyses will be separately conducted for neck and back pain, as well as for type 1 or type 2 diabetes.
 
Contact details for further information
Daniel Pozzobon
dpoz5597@uni.sydney.edu.au
 
Organisational affiliation of the review
University of Sydney
www.sydney.edu.au
 
Review team members and their organisational affiliations
Mr Daniel Pozzobon. USYD
Dr Leandro AC Nogueira. USYD
Professor Alison Harmer. USYD
Professor Paulo H Ferreira. USYD
Professor Manuela L Ferreira. USYD
 
Anticipated or actual start date
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Subject index terms status
Subject indexing assigned by CRD
 
Subject index terms
Back Pain; Diabetes Mellitus; Humans; Neck; Neck Pain
 
Date of registration in PROSPERO
30 November 2016
 
Date of publication of this version
30 November 2016
 
Details of any existing review of the same topic by the same authors
 
Stage of review at time of this submission
 
Stage Started Completed
Preliminary searches Yes Yes
Piloting of the study selection process Yes Yes
Formal screening of search results against eligibility criteria Yes No
Data extraction No No
Risk of bias (quality) assessment No No
Data analysis No No
 
Versions
30 November 2016
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This information has been provided by the named contact for this review. CRD has accepted this information in good
faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration
record, any associated files or external websites. 
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